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Abbreviations
Cyclic acid anhydrides
CA chlorendic anhydride
DSA dodecenylsuccinic anhydride
HA himic anhydride
HHPA hexahydrophthalic anhydride
MA maleic anhydride
MHHPA methyl hexahydrophthalic anhydride
MMA methyl maleic anhydride
MPA methyl phthalic anhydride
MTHPA methyl tetrahydrophthalic anhydride
PA phthalic anhydride
PMDA pyromellitic dianhydride
SA succinic anhydride
TBPA tetrabromophthalic anhydride
TCPA tetrachlorophthalic anhydride
THPA tetrahydrophthalic anhydride
TMA trimellitic anhydride
Other abbreviations
BAL bronchoalveolar lavage
ECD electron capture detector
FID flame ionisation detector
GC gas chromatography
GPSA guinea pig serum albumin
HPLC high performance liquid chromatography
HSA human serum albumin
MS mass spectrometry
NIOSH National Institute of Occupational Safety and Health
PVC polyvinyl chloride
RSA rat serum albumin
TLV threshold limit value
TWA time weighted average
UV ultraviolet
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11. Introduction
Cyclic acid anhydrides are widely used in the chemical industry, especially in
the manufacture of polyester and alkyd resins and plasticizers for thermoplastic
polymers. The anhydrides are also used as hardeners for epoxy resins and chain
cross-linkers for thermoplastic polymers. Workers are exposed to acid anhydrides
in powder form during various manufacturing processes, such as during synthesis
or when the acid anhydrides are used as starting agents for thermosetting products.
Workers are also exposed to anhydride fumes in hot processes, such as when
epoxy resins are hardened, polyester paints are cured, alkyd or polyester painted
metal surfaces are welded or when the paints are burned from surfaces.
Acid anhydrides are irritants and are especially potent as occupational
sensitisers.
Phthalic anhydride was the first anhydride to be reported as a sensitiser, as early
as 1939. Later several new derivatives were also found to be capable of inducing
allergies.
This document deals with the following cyclic organic acid anhydrides:
phthalic anhydride (PA), trimellitic anhydride (TMA), maleic anhydride (MA),
hexahydrophthalic anhydride (HHPA), methyl hexahydrophthalic anhydride
(MHHPA), methyl tetrahydrophthalic anhydride (MTHPA), tetrahydrophthalic
anhydride (THPA), and tetrachlorophthalic anhydride (TCPA). Other anhydrides
to be mentioned whenever data are available are pyromellitic dianhydride
(PMDA), himic anhydride (HA), succinic anhydride (SA), dodecenylsuccinic
anhydride (DSA), chlorendic anhydride (CA), and tetrabromophthalic anhydride
(TBPA).
This document updates the earlier one given by the Nordic Expert Group in
1991 (101).
2. Substance identification
Data on the substance identification of the cyclic acid anhydrides dealt with in this
document are given in Table 1 and Figure 1.
3. Physical and chemical properties
Data on the physical and chemical properties are presented in Tables 2a and 2b.
Cyclic anhydrides are mainly powders or crystals. Methyl substitution converts
them to oily liquids. A halogen – chlorine or bromine – in the molecule endows
flame retardant properties (178).
2Table 1. Substance identification of cyclic acid anhydrides (3, 24, 42, 139, 167).
Acid
anhydride
CAS No Synonyms Molecular
formula
Molecular
weight
PA 85-44-9 phthalic anhydride
1,3-isobenzofurandione,
1,2-benzenedicarboxylic acid anhydride,
phthalic acid anhydride,
1,3-dioxophthalan,
1,3-phthalandione
C8H4O3 148.12
TMA 552-30-7 trimellitic anhydride
1,3-dihydro-1,3-dioxo-5-isobenzofuran-
carboxylic acid anhydride,
trimellitic acid 1,2-anhydride
C9H4O5 192.13
MA 108-31-6 maleic anhydride
2,5-furandione,
cis-butanedioic anhydride,
toxilic anhydride
C4H2O3   98.06
HHPA 85-42-7 hexahydrophthalic anhydride
1,2-cyclohexanedicarboxylic anhydride
C8H10O3 154.17
MHHPA 25550-51-0 methyl hexahydrophthalic anhydride
hexahydromethyl-1,3-isobenzofurandione,
4-methylhexahydrophthalic anhydride
C9H12O3 168.19
MTHPA44
a 26590-20-5 methyl tetrahydrophthalic anhydride
1,2,3,6-tetrahydromethylphthalic anhydride,
3a,4,7,7a-tetrahydromethyl-1,3-isobenzofurane,
4-methyl-delta 4-tetrahydrophthalic anhydride
C9H10O3 166.19
THPA 85-43-8 tetrahydrophthalic anhydride
4-cyclohexene-1,2-dicarboxylic anhydride,
3a,4,7,7a-tetrahydro-1,3-isobenzofurandione,
1,2,3,6-tetrahydrophthalic anhydride
C8H8O3 152.16
TCPA 117-08-8 tetrachlorophthalic anhydride
4,5,6,7-tetrachloro-1,3-isobenzofurandione
C8Cl4O3 285.88
a4-methyl-delta 4-tetrahydrophthalic anhydride. Commercial products contain also isomers
3-methyl-delta 4-tetrahydrophthalic anhydride (MTHPA34) and 4-methyl-delta 3-tetrahydro-
phthalic anhydride (MTHPA43) (112).
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Figure 1. Structural formulas of cyclic acid anhydrides.
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54. Occurrence, production and use
4.1 Occurrence
Organic acid anhydrides are man-made chemicals commercially available at high
purity as liquids or crystals, depending on the type of anhydride. They are not
found in nature but may be found as environmental contaminants (183).
4.2 Production
The annual world production of PA has been about 2 200 000 tonnes during the
past decade, the European share being about 820 000 tonnes. The main producers
in Europe are Belgium, the United Kingdom, the Russian Federation, Italy, and
Germany. Of the Scandinavian countries, Sweden has production of PA, about
30 000 tonnes annually. PA production in 1996 was about 830 000 in Asia, about
420 000 in North America and 150 000 tonnes in South America. According to
annual export statistics Belgium, the United States and Italy are the main countries
to produce MA. The exported amounts were 58 000, 44 000, and 25 000 tonnes,
respectively, in 1997 (179).
4.3 Production processes
Industrial processes used in the production of cyclic acid anhydrides are shown
in Table 3. Technical anhydride products may contain other related cyclic
anhydrides as impurities or they can be mixtures of different isomers. For
example, PA contains 0.03% MA and MHHPA contains 4.2% MTHPA (150,
178). The technical product of MTHPA is reported to contain the three isomers
4-methyl-delta 4-tetrahydrophthalic anhydride, 3-methyl-delta 4-tetrahydro-
phthalic anhydride, and 4-methyl-delta 3-tetrahydrophthalic anhydride (112).
Table 3. Industrial processes used in the production of cyclic acid anhydrides (24, 178,
217).
Cyclic acid
anhydride
Production
process
PA In 1872 by oxidation of naphthalene. After 1960 by oxidation of o-xylene. The
technical grade product contains 99.9% PA, 0.03% MA, and 0.03% benzoic acid.
TMA Sublimation of trimellitic acid above its melting point or by heating crude
trimellitic acid with vanadium pentoxide.
MA Catalytic oxidation of benzene or C4 hydrocarbons.
HHPA Hydrogenation of THPA.
MHHPA Hydrogenation of MTHPA.
MTHPA Diels-Alder reaction between isoprene and MA.
THPA Diels-Alder reaction between MA and butadiene.
TCPA Chlorination of PA.
6Table 4. Annual import (in tonnes) of acid anhydrides in the Nordic countries and in the
Netherlands in 1997 (179).
Acid anhydride  Denmark Finland  Norway Sweden Iceland The Netherlands
PA 1 263 10 457         –a 2 784   –a 31 706
MA             –a 2 644 5 722 539   –a 7 177
aInformation lacking.
4.4 Use
The information available on the annual import of acid anhydrides in the Nordic
countries and in The Netherlands is shown in Table 4. In the trade reports the
cyclic acid anhydrides are mainly grouped with related chemicals.
The cyclic acid anhydrides are mainly used in the manufacture of polyester and
alkyd resins and plasticizers and as epoxy resin hardeners. The different types of
uses for acid anhydrides are presented in Table 5.
5. Occupational exposure data
The concentrations of organic acid anhydrides measured in workplace air are
presented in Table 6.
Early measurements of PA showed very high exposure levels (320-17 400
µg/m3) especially when process difficulties and in loading of reactors occurred
(136, 147). When alkyd and unsaturated polyester resins were produced, MA and
TMA were used in addition to PA (136).
In a more recent study, in which both particles and vapours were sampled, the
full-shift personal samples taken during the production of alkyd resins gave
10-100 fold lower concentrations of PA than in the previous studies. The task-
specific PA concentrations were higher, up to 1 860 µg/m3 during charging,
giving better information of the peak exposures during the working day. The
results of 3 factories were given. In 2 of the factories (factory 1 and 3), TMA and
MA were intermittently used in addition to PA and were only detectable in half of
the samples (182).
The PA concentrations during polyvinyl chloride (PVC) processing were low,
but measurable (180).
Exposure measurements of TMA were carried out during the manufacture of
cushioned flooring. The highest exposure levels were in charging (150-20 433
µg/m3), when both particles and vapours were sampled. Otherwise only few
values were above the occupational exposure limit 40 µg/m3 but the results were
based on few samples, 1-4 per task (182).
The exposure levels of MA have been low even in charging in the production
of alkyd resins (182).
In two plants for epoxy resin isolation, the highest HHPA concentrations were
found in casting (130-500 µg/m3) based on several personal samples. In one plant
7Table 5. Use of organic acid anhydrides (24, 42, 80, 140, 167, 178, 192, 195).
Acid anhydride Use
PA Manufacture of phthalate plasticizers, phthaleins, unsaturated polyester resins,
alkyd resins, halogenated phthalic anhydrides, and phthalocyanide dyes.
Preparation of benzoic acid.
Hardener in epoxy resins.
TMA Manufacture of plasticizers with high thermal resistance and of unsaturated
polyester resins.
Hardener in epoxy resins.
MA Manufacture of unsaturated polyesters, alkyd resins, lacquers, plasticizers, co-
polymers, lubricants, pesticides, pharmaceuticals, and permanent-press resins
(textiles).
Synthesis of some organic acid anhydrides.
Diels-Alder reaction.
HHPA Manufacture of alkyd resins, plasticizers, insect repellents, and rust inhibitors.
Hardener in epoxy resins.
MHHPA Hardener in epoxy resins.
MTHPA Hardener in epoxy resins.
THPA Production of unsaturated polyester resins and alkyd resins with increased
resistance to water and solvents.
Starting agent for light coloured alkyds, polyesters, and plasticizers used in
adhesives.
Intermediate for pesticides.
Hardener of epoxy resins.
TCPA Flame retardant in unsaturated polyester resins, polyurethane foams and
surface coatings and plasticizers.
Intermediate in the production of dyes and pharmaceuticals.
Hardener in epoxy resins.
PMDA Production of polyimide resins. Polyimide resins are high heat resistant
polymers with good electrical and physical properties. They are used for
films, fibres, moulding compounds, varnishes, and wire coatings.
HA Production of fire retardants.
SA Production of adhesives, dyes, and elastomers. It is used as a cross-linking
agent for epoxy resins and as a chemical intermediate for paints containing
drying oils, succinylated monoglyceride food emulsifiers, silver haloid
photographic emulsions, pharmaceuticals, alkyd resins, and plasticizers.
DSA DSA is used in alkyd, epoxy and other resins, anticorrosive agents,
plasticizers, and wetting agents for bituminous compounds.
CA Flame retardant in polyester resins and plasticizers.
TBPA Flame retardant in unsaturated polyester resins and moulding products.
8(plant A) also MHHPA was used and exposure levels up to 403 µg/m3 of MHHPA
were found in casting (195). In casting operations in, for example, the electronics
industry, solid or semi-solid anhydride curing agents (MTHPA, HHPA and
MHHPA) are heated, and the compounds are vaporised (sublimates). The major
exposure in these industries may derive from leakages from ovens during the
subsequent curing step (195).
When epoxy resin was handled in the wet part of the process in the manufacture
of barrels, MTHPA concentrations of 380 µg/m3 were measured, but exposure
levels up to 3 000 µg/m3 of MTHPA were found close to the heated, wet material
before curing (192).
In the manufacture of condensers 5 area samples were collected. The exposure
levels of MTHPA in assembling and hardening were between 36.5-695 µg/m3
(geometric mean). Earlier, before worsening of the work hygiene, 10-fold lower
concentrations of MTHPA had been measured (82).
TCPA exposure has been followed in the manufacture of solenoid coils when
TCPA cured epoxy resin was used. Exposure levels of 140-590 µg/m3 were
measured in the moulding. After improvements in work hygiene the exposure
levels were decreased to <10-110 µg/m3 (118).
When products containing rest monomers or esters of cyclic ortho-dicarboxylic
acids are heated, anhydrides tend to be released and sublimate into the ambient
air. This problem occurs in several work processes, e.g. in the curing of polyester
powder paints containing unsaturated polyesters at elevated temperatures. PA has
been detected when diethylhexyl phthalate, an ester plasticizer, is heated (147).
Cyclic anhydrides have also been detected in welding fumes from painted steel
(73, 102).
All cyclic anhydrides react with water, especially if warmed, and the corre-
sponding acid is formed.
When chlorinated anhydrides are heated to the point of decomposition, chlorine
is released and toxic vapours are emitted (111).
To conclude, the data on exposure measurements from the workplaces are
limited and the measurements have been prompted by work-related health
problems at the work place. Mostly the number of samples is small. When filters
are not used in the sampling, exposure in particulate form may be missed.
The highest exposure levels have been found in flaking, sacking, loading of
reactors and charging with anhydrides in solid form, especially with PA, TCPA,
and TMA. The exposure levels from the last decade have generally been lower
than the earlier ones pointing to the awareness of the harmful effects and to
improved occupational hygiene. Anhydride vapours and sublimates are found in
the work atmosphere when products containing anhydrides are heated. Often
several anhydrides as well as other sensitising or irritating agents are included in
the processes. This makes the exposure more difficult to assess. It is not possible
to group cyclic acid anhydrides according to vapour pressure because of lack of
data.
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6. Measurements and analysis of workplace exposure
6.1 Measurements and analysis of workplace exposure
Solid sorbent tubes are used for the collection of samples of vapours (Tenax,
XAD-2). A bubbler or impinger method is also possible. However, either device
will sample the anhydride as the corresponding acid. Therefore a derivatisation
step is needed in the analytical procedure. The impinger or bubbler method is also
efficient for the sampling of particles but not for small particles formed by, for
example, condensed vapour. Another possibility for sampling particles is to use
PVC or Teflon filters in series with solid sorbent tubes. To recover both particles
and vapours, sampling with both methods is recommended in studies of plants at
which the state of the exposure is unknown (87, 93). For analysis, gas chromato-
graphy (GC) with flame ionisation detection (FID), electron capture detection
(ECD) or mass-spectrometric (MS) detection has been used. Acetic anhydride
may be added to the eluting solutions to increase the stability of the samples in
the elution and analysis steps (87, 93).
6.1.1 Phthalic anhydride
Pfäffli sampled PA from air with Tenax polymer tubes and analysed PA by GC
utilising a 63Ni-ECD. The limit of detection was 0.4 µg/m3 (0.00007 ppm) with an
air sample of 12 1 (147, 149).
PA can also be analysed as the corresponding phthalic acid by reversed phase
high performance liquid chromatography (HPLC), as described by Nielsen et al.
(136).
6.1.2 Trimellitic anhydride
The Manual of Analytical Methods published by the National Institute for
Occupational Safety and Health (NIOSH) in the United States (US) gives method
5036 for measuring TMA. The air contaminants are sampled on a PVC copolymer
membrane filter. After treatment with methanol and boron trifluoride TMA is
analysed as its trimethyl ester by GC-FID. The detection limit is 2 µg per sample
(400 l air). The method does not differentiate between TMA and trimellitic acid
(138).
Geyer et al. collected samples on glass fibre filters and converted TMA to the
corresponding acid with a 0.05 M NaOH solution. The analysis was carried out
with HPLC with an ultraviolet (UV) detector. The minimum quantifiable amount
was 1 µg on a filter sample (sample size not given) (55).
Pfäffli modified the NIOSH method using a glass-fibre filter in series with a
Tenax tube. The analysis was carried out by GC-ECD. The detection limit was 0.6
µg/m3 (12 l of air and a sampling rate of 0.2 l/min) (148).
6.1.3 Maleic anhydride
The US NIOSH Manual of Analytical Methods gives method 3512 for measuring
MA. A known volume of air is drawn through a midget bubbler containing 15 ml
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of distilled water. Maleic acid is analysed by HPLC with an UV detector. The
limit of detection is estimated to 15 µg/m3 per sample. The method does not
distinguish between MA and maleic acid, and it has limited sample stability (138).
Geyer and Saunders used a similar method with 0.1% phosphoric acid in
distilled water as the absorbing solution and as the mobile phase. The minimum
quantifiable amount of MA was 100 µg/m3 of MA using a 100 l air sample (56).
The US Occupational Health and Safety Administration (OSHA) has described
an HPLC method for sampling MA, in which sampling is performed on p-anisi-
dine-treated XAD-2. Determination of the sampled anhydride using an ECD gave
a detection limit of 0.1 µg/m3 with a 12 l sample volume of air (87).
6.1.4 Hexahydrophthalic anhydride
Jönsson et al. reported a method where HHPA was sampled with XAD-2 or a
Tenax tube. The analysis was carried out with GC-FID. The detection limit was
0.1 µg/ml of desorption solution (87, 88).
HHPA has also been sampled with bubblers containing aqueous sodium
hydroxide (NaOH) and detected using GC with FID or electron ionisation MS
after derivatisation to dimethyl esters. The detection limit using electron ionisation
MS was 0.01 µg/sample (60 l of air) (87, 88, 93).
Glass-fibre filter sampling (eluted with aqueous NaOH, derivatisation with
pentafluorobenzyl bromide and determination by GC-MS in the negative-ion
chemical ionisation mode gave results comparable with those of the Tenax
method (93).
A Fourier transform infrared spectrometer has been tested for the direct
measurement of peak levels of HHPA. The limit of detection was 120 µg/m3
(117).
6.1.5 Methyl hexahydrophthalic anhydride
MHHPA has been sampled with Tenax tubes and analysed with GC-ECD (151).
When the sampling was carried out with XAD-2 tubes and analysed with GC-FID,
the detection limit was 0.1 µg/sample (sample volume not given). The detection
limit was equal for the cis and trans isomers of MHHPA (93).
6.1.6 Methyl tetrahydrophthalic anhydride
MTHPA has been sampled using Amberlite XAD-2 solid sorbent tubes and
analysed by GC-FID. The detection limit for air samples was 10 µg/m3 for a 20 l
sampling volume (189). The sensitivity was equal for the isomers in technical
quality of MTHPA (112).
Johyama et al. used silica-gel tubes for the sampling and GC-ECD for the
analysis. MTHPA concentrations >1.0 µg/m3 were quantified at 20 minutes
sampling with a sampling rate of 1 l/min (82).
6.1.7 Tetrahydrophthalic anhydride
THPA has been sampled with XAD-2 tubes and analysed using GC-FID. The
detection limit was 0.1 µg/sample (sample volume not given) (93).
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6.1.8 Tetrachlorophthalic anhydride
Liss et al. sampled TCPA with Teflon filters connected to Tenax tubes and made
the analysis using GC. No detection limits were given (118).
6.2 Measurements of dicarboxylic acids from samples of urine and plasma
Pfäffli reported a method for determining the dicarboxylic acids of PA, HHPA,
MHHPA, and THPA in urine. The acids were esterified with 2,2,2-trichloro-
ethanol and analysed by GC-MS. The detection limits were 2-4 ng/ml urine for
aliphatic and alicyclic acids, and 15 ng/ml for phthalic acid (151). In another study
by Pfäffli urine samples were collected from PA exposed workers pre-shift,
on-shift, post-shift, in the evening, and on the following morning. The samples
were esterified with boron trifluoride and methanol and analysed with GC-ECD.
The detection limit was 0.05 µmol/l (10 ml urine samples). A significant
correlation was found between the phthalic acid concentration in urine samples
and the atmospheric PA concentrations. When the exposure level was about 30%
of the hygienic reference value at that time 6 000 µg/m3, a body-burden was
caused which was not eliminated overnight (146).
Jönsson et al. used esterification with methanol and boron trifluoride and GC-
MS for the analysis. For HHPA-exposed workers a correlation was found between
time-weighted levels of HHPA in air and hexahydrophthalic acid in post-shift
urine (rs=0.93; p<0.023). The detection limit in urine was 20 ng/ml. Because the
urine analysis of one worker exposed to a HHPA time weighted average (TWA)
concentration of 30 µg/m3 showed that more than 85% of the inhaled amount was
excreted in the urine as hexahydrophthalic acid, it was estimated that it is possible
to monitor HHPA air concentrations of approximately 1-2 µg/m3 with this method
(86, 89).
Lindh et al. developed the method further for the analysis of methyl tetrahydro-
phthalic acid in urine. The commercial MTHPA used was composed of three
major isomers. The overall detection limit for the three isomers was <6 ng/ml
(112).
The method was further developed to be less labour-intensive in biological
monitoring and applicable for the determination of hexahydrophthalic acid and
methyl hexahydrophthalic acid. The detection limits in urine were 11 ng/ml and
17 ng/ml, respectively (84).
A method has been developed to measure hexahydrophthalic acid and methyl
hexahydrophthalic acid simultaneously in plasma. Pentafluorobenzyl bromide was
used as the derivatisation agent and the pentafluorobenzyl esters formed were
analysed by GC-MS. The detection limit was 0.4 ng/ml for hexahydrophthalic
acid and 0.3 ng/ml for methyl hexahydrophthalic acid (113).
6.3 Conclusions
Sensitive methods are available to measure air levels of exposure to cyclic acid
anhydrides at the workplace. It is important to choose sampling method according
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to the type of exposure. There are also sensitive methods for analysing the corre-
sponding dicarboxylic acids to PA, HHPA, MHHPA, MTHPA, and THPA in
urine, and dicarboxylic acids in plasma originating from HHPA and MHHPA.
7. Toxicokinetics
7.1 Uptake
When 5 healthy volunteers were exposed to gaseous HHPA at 80 µg/m3 for 8
hours, 1-4% was found in exhaled air during exposure. The concentration of the
metabolite hexahydrophthalic acid in plasma rose rapidly during exposure (90).
One worker was exposed to an 8 hour TWA concentration of HHPA of 30 µg/m3
and urine was collected during 24 hours. More than 85% of the inhaled dose was
excreted in urine as hexahydrophthalic acid (86).
HHPA (1 400 µg) in petrolatum was applied with the epicutaneous skin test
technique (4 Finn Chambers) to the back skin of 3 volunteers for 48 hours. The
volunteers´ urine was collected for 72 hours. The excreted amounts of hexahydro-
phthalic acid, as a fraction of the totally applied amount of HHPA, were within
intervals between 1.4-4.5%, 0.2-1.3% and 0-0.4%, respectively for the 3 subjects.
This indicated that the percutaneous absorption of HHPA was minimal. The
person with the highest absorption had pale erythema after the removal of the
mixture from the skin, a possible higher absorption through inflamed skin was
suggested (91).
There are no data on absorption via the gastrointestinal system.
In conclusion, absorption of HHPA via inhalation is efficient whereas dermal
absorption is low.
7.2 Distribution
Lindh et al. studied the distribution of HHPA by autoradiography after exposing
guinea pigs and rats to (3H2)HHPA via inhalation for 3-8 hours. Medium to high
levels of radioactivity were found in the mucosa of the nasal region and trachea,
whereas negligible levels were observed in lung tissue. Tissue-bound radioactivity
was also present in the gastrointestinal tract and conjunctiva. A low level of
tissue-bound radioactivity was found in the cortex of the kidneys in rat, but not
in guinea pigs. The radioactivity persisted for at least 7 days after the end of
the exposure. The HHPA-derived radioactivity could only partially be extracted
by organic solvents and water, suggesting a covalent binding to tissue macro-
molecules. However, in the lung, the little radioactive HHPA that was found could
also be extracted. The radioactivity in dialysed plasma was mainly found in the
same fractions as albumin (115).
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7.3 Biotransformation and excretion
Acid anhydrides are used to change the properties of proteins to separate them
from their matrix (141). The anhydride group reacts readily with amino acids and
this reaction explains their conjugation with human serum albumin (HSA), which
takes place in the hapten formation of acid anhydrides (175, 214). TMA was
conjugated with HSA rapidly in vitro at 37°C. The reaction was essentially
completed in 1 minute (214).
Plasma protein and albumin adducts have been measured in sera from HHPA-
and MHHPA-exposed workers. The adduct levels correlated well with the
exposure. The half-time of the adducts in vivo was about 20 days (161).
MTHPA was mainly bound to lysine in the collagen of guinea pig lung in both
in vitro and in vivo exposure tests (92). When human erythrocytes were exposed
to HHPA and MHHPA, conjugation with haemoglobin was found. The major
amino acid binding HHPA was also lysine (114).
Acid anhydrides are excreted in urine as the corresponding acids (dicarboxylic
acids).
Both in an animal study and when MHHPA-exposed workers were investigated,
it was shown that the hydrolysis of the anhydride in the body takes time (150,
166). MHHPA concentrations from 3.4-10.7 nmol/l were detectable after the
work-shift in the blood samples of workers exposed to MHHPA at levels between
140-310 µg/m3. The MHHPA found had the same cis form as in the air samples.
No free acids were found (150).
Pfäffli followed the excretion of phthalic acid in workers exposed to PA by
taking urine samples pre-shift, on-shift, post-shift, in the evening, and on the
following morning. At low atmospheric exposure to PA (150 (range 30-330)
µg/m3) the pre-shift phthalic acid concentrations were on the same level as those
found in the urine samples of occupationally unexposed people (0.34 (range
0.02-0.89) µmol/mmol creatinine). In workers exposed to higher concentrations
(1 630 (standard deviation (SD) 130) µg/m3 of PA) an accumulation of phthalic
acid in urine was found. The pre-shift phthalic acid excretion was 1.02 (SD 0.25)
µmol/mmol creatinine. When the exposure was high, 10 500 µg/m3, the pre-shift
urinary concentration was 4.8 µmol/mmol creatinine, about 14 times that seen in
workers with low exposure. No conjugation of phthalic acid to glucuronide was
observed (146).
The urine analysis of one worker exposed to a HHPA concentration of 30
µg/m3 (TWA) showed that more than 85% of the inhaled amount was excreted in
the urine as hexahydrophthalic acid (86).
The half-time of phthalic acid in urine of PA-exposed workers was shown to be
about 14 hours (146). The assumed half-time of the dicarboxylic acids in the urine
of workers with low exposure to MHHPA was about 7 hours, and for HHPA and
THPA the corresponding value was about 14 hours. After 4 hours of exposure to
an MHHPA concentration of 116 µg/m3 in air, an input-output equilibrium for the
anhydride and the urinary acid developed (151). In another study the half-time of
hexahydrophthalic acid in urine was 2-3 hours in HHPA-exposed workers (86).
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The half-times of hexahydrophthalic acid in plasma of 2 male healthy volunteers
were 1.7-1.8 hour after exposure to 80 µg/m3 HHPA for 8 hours (90). Urine
analysis indicated half-times of 3, 3 and 6 hours for the three isomers 3-methyl-
delta 4-tetrahydrophthalic anhydride, 4-methyl-delta 4-tetrahydrophthalic
anhydride, and 4-methyl-delta 3-tetrahydrophthalic anhydride, respectively in a
worker exposed to commercial MTHPA (112).
To conclude, cyclic acid anhydrides bind to plasma proteins and haemoglobin.
The main binding amino acid seems to be lysine. The half-time of MHHPA-
adducts has been shown to be 20 days. Cyclic acid anhydrides are after hydro-
lysation to corresponding dicarboxylic acids effectively excreted in urine. As
much as 85% of the inhaled dose of HHPA has been recovered in urine. The half-
time for the dicarboxylic acid of PA in urine was 14 hours, whereas the corre-
sponding half-times of HHPA, MHHPA and MTHPA were in general shorter,
between 2 and 7 hours.
8. Biological monitoring
Pfäffli analysed phthalic acid in urine of workers exposed to PA levels of 30-
10 500 µg/m3 (TWA) and found concentrations between 0.3-14.0 µmol/mmol
creatinine. At exposure levels of 2 000 µg/m3 of PA, phthalic acid could still be
detected in urine the next day (146).
Hexahydrophthalic acid in plasma and in urine of experimentally exposed
volunteers showed good correlation (r>0.90) with the air level of HHPA (90).
In another experiment the researchers studied 27 workers exposed to a mean
MHHPA concentration of 15 (range 5-60) µg/m3, mainly in casting and in leaks
from curing ovens in a plant manufacturing electrical capacitors. Urine was
collected during the last 4 hours of the shift and from 8 workers before the start of
the work shift and then at 4-hour intervals (7 hours during the night) for 24 hours.
Plasma was sampled at the end of the 8-hour work shift. The elimination half-time
in urine varied between 4 and 10 hours. Workers exposed to less than 10 µg/m3
had urinary levels below the quantification limit before the next shift. A
correlation (r=0.94) was found between the TWA air levels of MHHPA and
the creatinine-adjusted methyl hexahydrophthalic acid levels in urine samples
collected during the last 4 hours of the exposure and likewise between the
exposure and the plasma concentration of methyl hexahydrophthalic acid.
An exposure to 20 µg/m3 corresponded to a methyl hexahydrophthalic acid
concentration of about 140 nmol/mmol creatinine in urine and about 40 nmol/l
in plasma (116).
When protein adducts were measured in the plasma of HHPA and MHHPA
exposed workers, the concentrations correlated with the exposure levels. It was
shown that air levels even below 1 µg/m3 of HHPA and MHHPA were possible to
monitor (161).
In cross-sectional studies the proportion of persons with immunoglobulin (Ig)G
specific for PA, HHPA and MTHPA increased as exposure increased (136, 192,
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195). However, as 50% or more of the subjects were negative even in the groups
with the highest exposure intensity, the value of IgG as a biomarker of exposure
seems limited. This limitation is emphasised by the results of Jönsson et al. who
measured both haemoglobin adducts and HHPA-specific IgG antibodies in serum
in HHPA exposed workers. The exposure was determined from the analysis of
urinary carboxylic acid measurements. The authors found a correlation (r=0.87)
between the urinary hexahydrophthalic acid level and the number of haemo-
globin-HHPA adducts. However, there was no significant correlation between
the exposure and the HHPA-specific IgG (85).
In conclusion, measurement of the corresponding dicarboxylic acids in the urine
of exposed workers is a sensitive non-invasive method for biological monitoring
of some cyclic acid anhydrides. Measurement in plasma samples is also possible.
However, biomonitoring data and methods to measure the corresponding acids of
TMA, MA and TCPA are lacking.
The determination of specific IgG antibodies from blood samples does not
give information of the exposure level according to studies on HHPA-exposed
workers. Results obtained with determination of protein adducts (HHPA and
MHHPA) in plasma are more promising.
9. Mechanism of toxicity
9.1 Irritation
Cyclic acid anhydrides react easily with water, and the corresponding acids are
formed. The formation of acids explains the irritating effects on the skin and the
mucous membranes of the eyes and the respiratory organs (11, 15, 23, 45, 47, 122,
136, 171).
9.2 Allergic contact dermatitis (Type IV)
In animal studies PA has been classified as a moderate sensitiser causing allergic
contact dermatitis of type IV allergy (48). When the allergenicity of chemicals
was more recently studied using cytokine stimulation, PA, TMA, MA, HHPA and
MTHPA were not considered as contact allergens (31-33). The small number of
case reports also suggests that the potency of cyclic acid anhydrides to induce
allergic contact dermatitis is low (94, 96).
9.3 Contact urticaria (Type I)
IgE-mediated contact urticaria due to cyclic acid anhydrides is more usual.
MHHPA, MTHPA, HHPA, CA, and MA have induced contact urticaria in
exposed workers with specific IgE antibodies and positive results in skin prick
tests and in open tests with the anhydride (83, 94, 95, 102, 174). In some cases
airborne exposure without skin contact has resulted in contact urticaria (95, 174).
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9.4 Respiratory sensitisation
Allergic asthma, often preceded by rhinoconjunctivitis, is a well documented
disease of workers exposed to cyclic acid anhydrides, and its occurrence has
stimulated several works concerning the mechanism of the sensitisation. In case
reports and industrial surveys, IgE mediated sensitisation has been verified by
positive reactions in skin prick tests with conjugates of the anhydrides and HSA,
and by specific IgE. In exposed workers, bronchial hyperresponsiveness, a
typical finding in asthma, has been correlated to the specific sensitisation (14).
Immediate, dual, or late bronchial reactions have been found in challenge tests
with PA, MA, HHPA, MTHPA, TCPA, and PMDA (16, 17, 26, 36, 37, 108, 168,
184, 186, 196).
The formation of protein adducts in vivo is believed to be the first step in the
sensitisation process. This has been shown when total protein and albumin
adducts of HHPA and MHHPA were measured in the plasma of exposed workers
(161).
Also in sensitised animals the formation of anhydride-specific IgE and IgG
antibodies has been shown (4, 10, 68, 71, 217, 219, 220). In studies with PA,
TMA, and HHPA, an obstructive bronchial reaction has followed the challenge
tests of sensitised animals (10, 28, 68, 71, 165, 218).
There are some findings of mediator release in acid anhydride sensitivity.
When basophilic leukocytes were challenged in vitro with PA or TCPA-HSA
conjugates, there was a release of histamine, a mediator of allergic reaction. The
in vitro histamine assay was claimed to be useful in the identification of subjects
with allergic responses to anhydrides, even without evidence of IgE-mediated
reaction (44).
In animal studies using pretreatment with different blocking agents, the
mediators histamine and thromboxane A2 have been shown to be mainly respon-
sible for the early and late bronchoconstriction response to TMA. Leukotrienes
and histamine were found to mediate airway plasma exudation to some extent
(6, 8, 69, 71). In sensitised guinea pigs, pretreatment with budesonide signify-
cantly inhibited the increase in airway responsiveness, but not the eosinophilic
inflammation, induced by exposure to TMA dust (67).
Rats pretreated with the immunosuppressant cyclophosphamide showed no lung
lesions and no antibody reaction after exposure to 95 µg/m3 TMA 6 hours/day, 5
days/week for 2 weeks. Thus, the elimination of T- and B-lymphocyte function
could prevent the TMA-induced lesions (106).
Oral pretreatment with cyclosporin A inhibited the immunisation process
caused by TMA in guinea pigs, whereas betamethasone and azelastine had no
significant effect (5). In another study with brown Norway rats both betametha-
sone and cyclosporin A given over the time of sensitisation inhibited the
development of TMA specific IgE and IgG (155).
Activation of inducible nitric oxide synthase has been demonstrated in
bronchial tissue after TMA-guinea pig serum albumin (GPSA) challenge in
sensitised guinea pigs (198).
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The pulmonary disease-anaemia syndrome described due to fumes from TMA-
cured epoxy resin, is a rare disease with haemorrhagic alveolitis and specific IgG
antibodies. In animal studies similar reactions have been found (25, 107).
9.5 Conclusion
Cyclic acid anhydrides are irritants because of formation of corresponding acids in
wet surroundings. They rarely induce contact allergy of the skin but more easily
induce IgE-mediated contact urticaria. The mechanism of respiratory sensitisation
is mainly IgE mediated allergy both in animal studies and when exposed workers
have been investigated. In the challenge tests bronchial obstruction has been
verified, as well as development of inflammation. The determination of specific
antibodies and mediators of allergies and allergic inflammation in the studies with
cyclic acid anhydrides has given new information on allergic reactions in general.
10. Effects in animals and in vitro studies
10.1 Irritation and sensitisation
10.1.1 Irritation
In animal studies PA has not been found to be as irritating as MA and TMA
(Table 7).
A PA solution (50%) in oil did not irritate rabbit ears after 20 hours of exposure
(34). PA (0.5 g/patch) did not cause skin irritation on rabbits when applied by the
semi-occlusive or occlusive method over a period of 1 or 4 hours. The results
were assessed at 1, 24, 48 and 72 hours, or 7 days later (154).
One drop of PA (5%) in polyethylene glycol 400 was slightly irritating to rabbit
eyes, while a 0.5% solution was not irritating (34). In an experiment with rabbits,
the irritant effects of PA on the skin and eyes correlated with each other. PA was
found to be a mild skin irritant, but a moderate eye irritant (47).
TMA (50%) caused dermatitis in mice and rats after a single or repeated
application to the skin for 2 hours. The effects were slight and reversible (15).
MA and TMA have been shown to be extremely irritating to eyes in animal
experiments. There was cloudiness of the cornea and hyperaemia of the con-
junctiva a few minutes after the application of 1% MA to the eyes of rabbits.
The next morning the eyes were normal. A 5% solution of MA induced more
intense irritation, which lasted 1 week. A minute amount of MA powder caused
long-lasting damage with vascularisation of the cornea of the rabbit (197).
The application of 50 mg of TMA powder to rabbit eyes produced reversible
hyperaemia of the conjunctiva, and lacrimation and blepharospasms (15).
In a 6-month inhalation study on MA, rats, hamsters and monkeys were
exposed to concentrations of 0, 1 100, 3 300, and 9 800 µg/m3, 6 hours/day for 5
days/week. Dose-related ocular and nasal irritative signs were present at all
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Table 7. Irritative and sensitising effects of acid anhydrides on different animal species.
Anhydride/
Species
Route of
administration
Exposure data Effect   Reference
PA
Rabbit Eye application 50 mg Moderate irritation (139)
Rabbit Dermal (patch) 500 mg (1 or 4 h) No skin irritation (154)
Rat, Brown
Norway
Intradermal 0.1 ml 0.2 M PAa Specific IgE and specific
IgG antibodies
(220)
TMA
Rabbit Eye application 50 mg Conjunctival hyperemia,
lacrimation
(15)
Guinea pig Intradermal 0.1 ml of 30% TMA Specific IgG1 and IgE
antibodies
(22)
a
 Specific IgE and IgG antibodies have been induced in similar studies with TMA, MA, HHPA,
MHHPA and MTHPA (220).
exposure levels. A histopathological examination of nasal tissue (turbinate
sections immediately posterior to the upper incisors) revealed irritation
(hyperplasia, metaplasia) in rodent species and inflammatory changes in all
species. All changes were judged to be reversible (171).
10.1.2 Allergic contact dermatitis
The potency of PA to induce allergic contact dermatitis has been investigated with
the Buehler test (closed patch test in guinea pigs) and the mouse ear swelling test
(MEST). According to both tests PA was classified as a moderate sensitiser (48).
The guinea pig maximisation test has not been carried out with acid anhydrides.
In other studies investigating the patterns in cytokine production following
topical sensitisation, PA, TMA, MA, HHPA and MTHPA were not found to be
contact allergens (31-33).
10.1.3 Respiratory sensitisation
Table 8 contains data from the respiratory sensitisation studies. Sensitisation
with the production of specific antibodies is essential for the development of
an allergic respiratory disease. Antibody response has been induced by both
bronchial, subcutaneous, intradermal and parenteral sensitisation routes.
When monkeys were exposed parenterally to PA-monkey serum albumin
(MSA), PA dissolved in ethanol saline, MSA, or ethanol-saline alone, sensi-
tisation was observed only with PA-MSA. The presence of new antigenic
determinants formed by PA on protein carriers was essential for the parenteral
sensitisation (21).
Guinea pigs were sensitised by inhalation of PA dust at 500, 1 000, 5 000
µg/m3, for 3 hours/day for 5 consecutive days. A PA-guinea pig serum albumin
(GPSA) challenge after 2 weeks elicited an immediate onset of respiratory
reactions, determined by plethysmography, in animals exposed to all 3 levels of
dust. The inhalation challenge with PA dust (5 000 µg/m3) did not cause an
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immediate response, but the animals had significant number of haemorrhagic
lung foci. No foci were seen in the lungs of PA-GPSA challenged animals. IgG-
PA-GPSA antibodies were detected in sera of all the PA-exposed animals, and the
dose-response relationship was highly significant (165).
In a Japanese study rabbits were sensitised subcutaneously to PA-rat serum
albumin (RSA). High titres of IgG against PA-RSA were found, but also against
PA-HSA and HSA. IgG-PA-HSA antibodies had cross-reactivity with HHPA-
HSA, MHHPA-HSA, and MTHPA-HSA. After purification of specific IgG-PA,
the levels of specific IgG to other conjugates were unchanged. Two types of IgG
antibody production were suspected, one to PA hapten alone and the other to new
antigenic determinants on HSA (66).
Dykewicz et al. sensitised 2 rhesus monkeys intrabronchially with serum from a
worker with TMA asthma and high titres of IgE, IgG, and IgA to TMA-HSA. The
monkeys were challenged with TMA-HSA aerosol and bronchospasm appeared.
After 1 week the challenge was negative. Passive cutaneous anaphylaxis was also
found with the Prausnitz-Küstner test (38).
In an inhalation experiment rats were exposed 3 hours/day for 5 days to 0, 10,
30, 100 or 300 µg/m3 of TMA dust. Haemorrhagic lung foci were found in rela-
tion to exposure concentrations of 30-300 µg/m3. The serum antibody binding of
trimellitic-RSA correlated with exposure concentration, presence of haemorrhagic
lung foci and lung weight. The lung lesions had healed 12 days after the exposure,
but returned soon after a repeated exposure (211). A histological examination of
the lung lesions indicated extensive cellular infiltration, primarily macrophages,
alveolar haemorrhage, and pneumonitis. These effects increased in proportion to
the concentration. The lungs were the only organs affected (107).
Chandler et al. exposed rats to TMA powder (100 µg/m3) for 6 hours/day, 5
days/week for 2 weeks. Haemorrhagic foci were observed on the surface of the
lungs at autopsy. The authors found higher total antibody concentrations in the
fluid of bronchoalveolar lavage (BAL) than in serum. IgG, IgA, and IgM anti-
bodies to TMA-RSA were detected. Inhibition studies showed that both TMA-
RSA and TMA-HSA conjugates cause complete inhibition of the rat IgG binding,
whereas the human IgG was inhibited only by TMA-HSA. The early antibody
response in the rat was directed towards new antigenic determinants common to
TMA-modified albumins (25). The immune response to inhaled TMA has been
found to occur in parallel with the development of lung lesions. The antibody
levels in BAL and serum were highly correlated with the lung injury (209).
After rats had inhaled TMA powder (500 µg/m3 or 330 µg/m3) on days 1, 5 and
10 for 6 hours/day they were challenged with TMA (540 µg/m3 or 300 µg/m3), on
day 29 or 22, respectively. In the high exposure group, IgM and IgA antibodies to
TMA-RSA started to increase from day 5 and peaked at day 20. IgG antibodies
appeared on day 7 and peaked at day 20. A mean of 216 haemorrhagic lung foci
was found. In the low exposure group animals that were not rechallenged had
fewer lung foci than the rechallenged animals. In the rechallenged group there was
a correlation between all the antibody measures and lung injury. A subgroup of
animals was exposed to a TMA level of 500 µg/m3 only on days 1 and 5 and
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challenged with 500 µg/m3, on day 29. A mean of 112 haemorrhagic lung foci
was found, and there was a good correlation between the antibody response and
the lung injury (208).
Hayes et al. developed a guinea pig model for TMA-induced airway hyper-
sensitivity responses by sensitising animals intradermally with 0.1 ml of 0.3% free
TMA in corn oil. Control animals were given 0.1 ml corn oil. An increase in the
level of specific serum IgG1 antibodies was found in all sensitised animals, and
IgE antibodies were detected in 6 of 8 sensitised animals. On days 21 to 28 a
tracheal challenge (50 µl) with 1% TMA-GPSA gave increased lung resistance in
sensitised animals compared with non-sensitised animals. Airway microvascular
leakage was also seen in sensitised animals when tested with Evans blue (70).
When challenged by inhalation through the nose (12 000 µg/m3 TMA, 30
minutes), the animals showed a significant increase in bronchial reactivity 8 hours
after the exposure, and the increase was accompanied by an eosinophilic inflam-
matory exudate (68).
Arakawa et al. investigated the time course of immune and airway responses
after sensitising guinea pigs through two intradermal injections (0.1 ml of 0.3%
TMA in corn oil). They challenged the animals after 1, 2, 3, 5 and 8 weeks with
50 µl of 0.5% TMA-GPSA intratracheally. The challenge induced a significant
increase in lung resistance, reaching a maximum at 2.5 minutes in the 1-week
group and between 5 and 6 minutes in the other sensitised animals. A significant
extravasation was also found that increased up to 8 weeks. Specific IgG1 anti-
bodies were detected in all the animals in the 3-, 5-, and 8-week groups; this result
correlated with the extravasation but not with the increase in the resistance (7).
Brown Norway rats were intradermally sensitised with TMA and then chal-
lenged once or seven times with TMA-RSA conjugate. High levels of TMA-
specific IgE and IgG were found in all the sensitised rats when they were
compared with controls. A single allergen challenge did not cause bronchial
hyperreactivity but repeated challenge produced significant bronchial hyper-
reactivity in sensitised rats. Repeated, low-dose challenges produced more
hyperreactivity than a 10 times higher single dose. Bronchial eosinophilia was
found in the sensitised and single-challenged groups, but not in the non-sensitised
non-challenged and sensitised re-challenged groups (28).
Inhibiting complement activation prevented inflammatory cell infiltration in
TMA-induced asthma. This phenomenon was studied by pretreatment of guinea
pigs with a cobra venom that reduced the complement component C3 in broncho-
alveolar lavage fluid after TMA-GPSA challenge. The immediate bronchocon-
striction was not affected, nor was the microvascular leakage. The TMA-induced
increase in mononuclear cells, total white blood cells and red blood cells, and the
erythrocyte peroxidase activity was reduced (46).
When sensitised brown Norway rats were challenged, TMA induced an imme-
diate bronchoconstriction. Eosinophilic aggregates and goblet cell hyperplasia
and hypertrophy were seen in the lungs and also induction of haemorrhages in
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sensitised animals. A less marked eosinophilic infiltration of the lungs was seen
also after the challenge tests of the non-sensitised animals (10).
Zhang et al. studied the mechanism of allergy by developing a regime for the
intradermal sensitisation of guinea pigs to HHPA. The animals were immunised
by an intradermal injection with single and booster injections of 0.1 ml of 0.02%,
0.1%, 0.5%, 5%, and 10% mixtures of HHPA in olive oil. Single injections of
<0.5% produced no positive findings of specific IgE or IgG antibodies. A single
injection induced optimal levels of IgG after 14 days at a dose of 5% HHPA. The
IgE titres were low and only positive in 40-50% of the animals at injections of
0.5-10% HHPA. For IgE induction, booster injections were needed (217). The
authors also studied the relationship between specific IgG1 levels and airway
responses to predict the sensitising potential of acid anhydrides. They concluded
that allergen challenge in HHPA-sensitised guinea pigs results in both airway
obstruction and plasma extravasation, and that responses are related to the serum
levels of specific IgG1 (218, 219).
Anaphylactic bronchoconstriction has been induced in guinea pigs sensitised
with HHPA or MTHPA and challenged by inhalation or intravenously with the
corresponding GPSA conjugate. A steep dose-response relationship was found.
The critical dose was accordingly established to be approximately 40 µg/kg (221).
A model to differentiate chemicals for different types of allergenicity has been
developed. Mice were sensitised topically, by applying the test material dissolved
in 4:1 acetone:olive oil, to a shaved flank under an occluded patch for 48 hours.
After 5 days the ear thickness was measured, and then the dorsum of both ears
was treated with 25 µl of the tested chemicals, TMA, and 2,4-dinitrochloro-
benzene, the later being a potent contact allergen without respiratory sensitisation
properties. When the levels of activation (cell proliferation) in lymph nodes
draining the site of application were similar, comparable levels of contact
sensitisation and IgG anti-hapten antibodies were induced by these chemicals, but
only TMA increased the IgE production. Furthermore, while TMA induced IgG2b
rather than IgG2a antibodies, the reverse pattern was observed with the contact
allergen. The results pointed to a different type of T lymphocyte (Th1 and Th2)
response to these chemicals (31). A similar response has been found with PA,
MA, HHPA, and MTHPA (32, 33). Arts et al. used brown Norway rats in a very
similar setting with TMA, dinitrochlorobenzene, formaldehyde, and methyl
salicylate. They also found a significant increase in the serum IgE concentration
after exposure to TMA but not after exposure to the other chemicals, skin
sensitisers, or irritants (9).
Welinder et al. studied the relationships between chemical structure and
immunogenicity for 13 dicarboxylic acid anhydrides in guinea pigs intra-
dermally sensitised with SA, MA, methyl maleic anhydride (MMA), cis-HHPA,
trans-HHPA, MHHPA, cis-1,2,3,6-tetrahydrophthalic anhydride (THPA1236),
cis-3,4,5,6-tetrahydrophthalic anhydride (THPA3456), MTHPA34, MTHPA44, PA,
4-methyl phthalic anhydride (4-MPA) and TMA. Specific IgG was significantly
increased in all animals except those immunised with THPA3456 and SA, which
sensitised some but not all the animals. The titres of specific IgG1 and IgG2 were
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increased in IgG-positive animals. Passive cutaneous anaphylaxis test was used
for determining specific IgE. Specific IgE was positive in all the animals immu-
nised with MA, MHHPA, MTHPA (both isomers), and 4-MPA and in 6/9 and 5/9
guinea pigs immunised with TMA and MMA, respectively. The test results were
contradictory for PA and HHPA. The sensitising potentials of different organic
acid anhydrides showed a considerable variation. The substitution of hydrogen in
the C4 position by a methyl group or adding a double-bond to the same position
enhanced the immunogenicity of the anhydrides (194, 219). In brown Norway rats
sensitised intradermally with 14 different acid anhydrides (0.1 ml of 0.2 M) or 3
anhydride conjugates (1 400 µg of RSA conjugate) specific IgE antibodies were
measured after 4 weeks. The titres (median) obtained after sensitisation with free
MPA, PA, cis-HHPA, 4-MHHPA and TMA were 1 600-3 200 (range 800-6 400)
and after sensitisation with MA, THPA1236 and both isomers of MTHPA the titre
was 800 (range 200-3 200). SA as free was negative, but in conjugate form,
positive titres of specific IgE were found as well as with MA and cis-HHPA
conjugates (220).
The specificity of the antibodies was studied with inhibition tests. The
anhydrides with methyl group or double-bond similar to the sensitising anhydride
caused higher inhibition effect when compared to the anhydrides with different
structures (217, 219, 220).
In conclusion, specific IgE and specific IgG antibodies (PA, TMA, HHPA,
MHHPA, and MTHPA) have been measured as a marker of sensitisation in
animals after immunisation. In guinea pig studies methylation and the presence of
a double bonding in the C4 position of the anhydride molecule enhanced the
sensitising potential. However, the results of the studies with brown Norway rats
were partly different. In inhibition studies cross-reactivity was shown between
anhydrides with similar structures. In challenge studies of sensitised animals,
bronchial responses similar to bronchial asthma in humans have been seen. TMA
dust evokes a lung reaction in animals that is similar to the pulmonary disease-
anaemia syndrome.
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Table 9. Acute lethality data for organic acid anhydrides.
Anhydride Species Route of
administration
LD50
(mg/kg bw)
Reference
PA Cat Oral 800 (139)
Rat Oral 1 530 (139)
Mouse Oral 1 500 (139)
Mouse Intraperitoneal 75.5 (41)
TMA Mouse Oral 1 900 (15)
Rabbit Oral 5 600 (139)
MA Rat Intraperitoneal 97 (139)
Rat Oral 400 (139)
Guinea pig Oral 390 (139)
Mouse Oral 465 (139)
Rabbit Oral 875 (139)
Rabbit Dermal 2 620 (187)
MTHPA Rat Oral 2 140 (173)
THPA Rat Oral 5 410 (167)
TCPA Rat Oral >15 800 (167)
Rabbit Dermal >5 000 (167)
10.2 Effects of single and short-term exposure
Table 9 presents compiled data on the lethal dose for 50% of the exposed animals
at single administration (LD50) of organic acid anhydrides. PA and MA have the
lowest LD50 -values in animal studies. In rats the oral LD50 values are 400 and
1 530 mg/kg, respectively. TCPA is the least acutely toxic anhydride with LD50
value >15 800 mg/kg orally in rats.
Oral TCPA (7 days, at 25 000, 100 000, 250 000 or 500 000 µg/kg in corn oil)
has been shown to be a weak wide-spectrum inducer of microsomal enzymes in
rats. A similar effect was not observed for mice (159).
10.3 Effects of long-term exposure and carcinogenicity
When rats, hamsters and monkeys were exposed to MA vapours (1 100-9 800
µg/m3) for 6 months, no exposure-related effects were found in histopathological
investigations of lungs, liver, spleen, bone marrow or kidneys. A histopathological
examination of nasal tissue revealed irritation (hyperplasia, metaplasia) in rodent
species and inflammatory changes in all species. All changes were judged to be
reversible. In the metaplastic changes the cuboidal to low columnar epithelium
became hyperplastic and pseudostratified. Transformation to nonkeratinising
squamous-type epithelium was seen. Metaplastic changes were present at all dose
levels with a nonlinear increase in incidence (171).
When rats were exposed to HHPA vapours at 34 300, 68 600 or 137 300 µg/m3
(6 hours/day, 5 days/week for 2-11 weeks), their cerebral and cerebellar acetyl-
cholinesterase activity was below the control range at 137 300 µg/m3 after 2
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weeks (p<0.01). After 11 weeks the activities had normalised to control levels.
The creatine kinase activity increased in the cerebellar tissue after 11 weeks of
exposure (p<0.01) (166).
Information on carcinogenicity of acid anhydrides is scarce. No evidence of
carcinogenicity was found for PA in long-term feeding studies with rodents (65,
103, 104, 169).
When 6 rats where injected subcutaneously twice weekly with 2 000 µg of SA
in 0.5 ml of arachis oil for 65 weeks, subcutaneous sarcomas developed at the
injection site in the 3 rats that had survived 93-106 weeks. No tumours occurred in
the 24 controls injected with arachis oil alone. The controls survived 45-106
weeks (77).
10.4 Mutagenicity and genotoxicity
No mutagenic activity has been found with PA, TCPA, or TBPA in Salmonella
typhimurium in Ames test (121, 207). No effect of PA or TCPA was found on
chromosomal aberrations neither in cells derived from Chinese hamster ovary
cells nor in rat liver cells in vitro (49, 152).
Furthermore, when Chinese hamster ovary cells were tested for the induction of
sister chromatid exchanges, PA and TCPA produced negative results (49). In a
later chromosome aberration study using a higher and cytotoxic PA concentration
(10 mM), an 18.5% increase in aberrations was seen compared to 3% in the
control test (75).
There are no data on the mutagenicity or genotoxicity of other cyclic
anhydrides.
10.5 Reproductive and developmental studies
Fabro et al. studied the teratogenicity of PA and SA in mice with daily intraperi-
toneal injections at doses of 0.2 to 0.6 mmol/kg/day on gestation days 8-10. They
found malformations only at exposure levels of maternal toxicity (41).
No effects on reproduction were observed in CD-l mice when TMA (550 000
µg/kg) was given orally on days 7 through 14 of gestation (72).
No treatment-related effects on foetal development were seen in rats treated
orally with MA in corn oil at a dose of 140 000 µg/kg/day from days 6-15 of
gestation. Furthermore, no treatment-related effects on reproduction were
observed with MA at doses up to 55 000 µg/kg/day over 2 generations (170).
PA caused malformations at a high frequency when 200, 100, 50, or 25 µg
of PA per egg was injected into the air chamber of the egg of 3-day chicken
embryos. A dose-response effect was found for early (105).
In conclusion, there is no evidence of teratogenic effects. However, only a few
cyclic anhydrides have been tested.
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11. Observations in man
Observations on human exposure are based on case reports of occupational
sensitisations, industrial surveys, and some experimental human studies. In early
reports the information on exposure levels is limited.
In humans, cyclic anhydrides cause irritation and sensitisation after direct
contact with the skin and the mucous membranes or after exposure by inhalation
(215).
The irritative symptoms (itching, lacrimation, sneezing, rhinorrhoea, cough,
and dyspnoea) begin immediately at exposure to high concentrations of dust or
vapours. The most common allergic diseases are rhinoconjunctivitis and asthma,
both immediate-type IgE-mediated allergies. Also late-type respiratory symptoms
with specific IgG antibodies have been described. A less frequent consequence
is the severe disease called pulmonary disease-anaemia syndrome, and contact
eczema, contact urticaria, allergic laryngitis, and allergic alveolitis. One case of
haemolytic anaemia in an MA-exposed worker has also been reported.
11.1. Irritation and sensitisation
Conjunctival, nasal, and bronchial irritation is a common immediate feature
following exposure to acid anhydrides (11, 126, 135, 136, 214). On mucous
membranes and on sweating skin, they are hydrated to acids and can cause
irritation, reddening, corneal damage, caustic dermatitis, and burns (122, 126).
The human nasal irritation threshold for PA has been reported to be 30 000
µg/m3 and that for MA is 5 480 µg/m3. However, exposure duration, generation
of particles and particle sizes were not given (162).
Nielsen et al. studied 60 workers exposed to mean levels of 400 µg/m3 PA
with peak levels of 6 600 µg/m3 during the loading of reactors. Of the 35 heavily
exposed workers, 5 (14%) had asthma and 24 (69%) reported work-related
symptoms of rhinitis and/or conjunctivitis. All the asthmatics were loaders. Four
subjects had positive specific IgE, and 1 of the 4 suffered from asthma (136). The
results indicate an irritative, non-allergic effect of PA on the mucous membrane.
In a follow-up study, no significant effect on large airways, small airways, or
alveolae was observed in the group of loaders when they were compared with the
unexposed controls (130). When 20 HHPA-exposed subjects with work-related
nasal symptoms were investigated, only 11 HHPA sensitised persons had positive
reactions in the specific nasal challenge tests. The challenge test was negative in 9
subjects, all of them without HHPA sensitisation according to skin prick tests and
determination of HHPA specific IgE antibodies but who nonetheless had irritant
symptoms upon HHPA exposure (135).
Irritant haemorrhagic rhinitis has been reported as a result of MA exposure (18).
There is one report of anhydride-induced reactive airways dysfunction
syndrome (RADS). RADS is characterised by damage of the bronchial epithelia
followed by neurogenic inflammation and asthma (51). The person experienced
acute mucosal symptoms immediately after an accidental 10-minute exposure to a
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high concentration of PA. Symptoms of asthma developed, and 2 months later a
nonspecific bronchial hyperreactivity was verified, which resolved after about
3.5 years (45).
11.2 Effects of repeated exposure on organ systems
Allergic reactions of the skin and conjunctiva and allergic respiratory manifes-
tations are well known effects of occupational exposure to cyclic anhydrides.
Respiratory diseases include occupational allergic rhinoconjunctivitis and
occupational asthma. Urticaria and allergic rhinoconjunctivitis often precede
asthma. Cases of haemorrhagic alveolitis, haemorrhagic anaemia, allergic
alveolitis, and allergic laryngitis have also been reported in association with
exposure to anhydrides.
In industrial surveys the prevalence of occupational asthma due to different
anhydrides has varied between 8-18% in those exposed to PA, 2-11% for TMA
exposure, 15% for HHPA exposure, 11% for MHHPA exposure and 3-39%
for TCPA exposure (203). According to the Finnish Register of Occupational
Diseases, cyclic acid anhydrides caused the following numbers of diseases relative
to the total numbers in 1997-1999: asthma 1/902, rhinitis 14/1 001 and contact
urticaria 8/478. There were no reports of allergic alveolitis or allergic contact
dermatitis (97-99).
There are no data showing an effect on other organ systems.
11.2.1 Allergic dermatitis
DSA sensitised a laboratory technician who prepared tissues for electron micro-
scopy. The delayed-type allergic reaction was verified with positive patch tests
with 0.5-1% DSA in acetone. Tests on 15 controls were negative. The patient did
not react to epoxy resin, accelerator or another hardener (57).
A worker who used a horizontal boring machine contracted allergic contact
dermatitis when exposed to MHHPA. Patch testing with a dilution series of
MHHPA in petrolatum gave the following positive results: 2%, 1% and 0.5% ++;
0.25% and 0.125% +. Immunohistochemical and electron microscopic observa-
tions indicated that the patch test reactions were conventional delayed allergic
reactions. The patient also had an immediate-type contact dermatitis due to
exposure to MHHPA, verified with positive skin prick tests and presence of
specific IgE antibodies, and also erythematous skin symptoms in a chamber
provocation test with MHHPA (96).
In a cross-sectional dermatological examination, 190 workers at 5 ceramics
factories were investigated. The patch test series included MA (1% in ether) and
PA (1% in petrolatum). Two workers had a positive patch test reaction to MA; no
other data were available on these cases. The authors reported that, earlier, MA
had been involved in 3 cases of skin sensitisation (129).
In 1955 urticarial reactions were reported among workers in PA production by
Menschick (126) and Baader (11). There are, however, only a few case reports of
immediate-type dermatitis due to acid anhydrides. MHHPA induced contact
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urticaria in a worker from a factory where electronic components were filled with
MHHPA-cured epoxy resin. The sensitisation was confirmed with the open test,
which gave a positive reaction with the filling mixture and the hardener tested
separately. Open tests with all the other components were negative, as were the
epicutaneous tests with all the components. Open tests with the hardener were
negative for 12 control persons (83). Tarvainen reported 2 cases of contact
urticaria, one due to MHHPA, and the other due to MTHPA. Neither person had
had skin contact with the anhydride; instead the exposure had only been airborne.
Symptoms of urticaria began after 2 months of exposure. Later, conjunctivitis,
rhinitis, and asthma symptoms also developed. An IgE-mediated allergy was
diagnosed by means of skin prick tests and specific IgE antibodies (174). Another
case of airborne contact urticaria due to MHHPA and HHPA has been reported for
a winder in the electronics industry (95). CA has caused contact urticaria in a
welder exposed to welding fumes of chlorinated polyester paint containing CA.
An IgE-mediated allergy was verified with skin prick tests and specific IgE
antibodies, and an open test with CA was also positive (102). MA has caused
contact urticaria in an operator exposed to MA dust in a firm manufacturing
polyester resin (94).
In conclusion, allergic dermatitis due to cyclic acid anhydrides is rare. There are
only two case reports on delayed-type contact allergy, due to DSA and MHHPA.
IgE mediated contact urticaria is more common, induced by contact or sometimes
even airborne exposure to MA, MHHPA, MTHPA, HHPA and CA.
11.2.2. Respiratory allergies
Kern reported the first case of occupational asthma caused by an organic acid
anhydride as early as 1939 (100). During the last 10 years a growing number of
cases of asthma or rhinoconjunctivitis due to different acid cyclic anhydrides has
been reported. The symptoms have been those of typical occupational asthma and
rhinitis. After a symptom-free latency period the worker experiences symptoms
when exposed to acid anhydrides at the workplace. The diagnosis has been based
on the exposure, symptoms, and a cause-effect relationship proved with immuno-
logical tests or challenge tests. In industrial surveys the diagnosis has often been
based on questionnaire and immunological studies.
Reports of occupational asthma are presented in Table 10 according to the
exposure. The more rare sensitising anhydrides are PMDA (epoxy glue (125),
production of PMDA (18)), HA (manufacture of synthetic flame-retardants, (160))
and CA (in fumes of polyester paints, (102)). There are no reports of THPA- or
TBPA-induced cases of occupational allergy.
Data from the industrial surveys on the findings of antibody formation and
symptoms are compiled in Table 11.
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Table 10. Type of industry or occupation in reports of occupational rhinitis and asthma.
Acid anhydride Exposure situation/occupation Reference
PA PA production (128)
Production of alkyd or unsaturated polyester resins (13, 136, 196)
Paint factory (43, 100)
Varnish production (54)
Plastic grinder (188)
Chemical foreman (120)
Tyre and rubber manufacture (27)
Meat wrapper/price label fume (110)
TMA TMA production (216)
Mixing of TMA powder to epoxy resin (164)
Epoxy powder painting (43, 109)
Manufacture of cushioned flooring (13)
MA Epoxy resin insulation (64, 171)
MA production (50)
Alkyd or polyester resin production (13, 108)
HHPA Epoxy resin moulding (127)
Isolating of components for the electronics industry (195)
Production of electrical capacitors (195)
Production of epoxy hardener (26)
MHHPA Filling of electric components (163)
MTHPA Epoxy resin coating (133, 137, 199)
TCPA Epoxy resin production (168)
Epoxy resin coating (76)
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Determinations of specific antibodies
The proof of IgE mediation in immediate-type asthma or rhinitis due to acid
anhydrides is convincing. When Kern reported the first case of asthma and rhinitis
due to PA in 1939, he already had evidence of the immunological background.
The scratch test with PA in crystalline form and diluted 1:1 000 in alcohol gave
positive reactions. The tests with control patients were negative. The passive
transfer test was also positive (100). Maccia and his colleagues were the first to
find specific IgE in the serum of a patient with asthma due to PA in 1976. The
patient experienced an immediate asthmatic reaction in the provocation test with
PA dust (120).
Specific IgE has been found to PA, TMA, MA, TCPA, HHPA, HA, MHHPA,
MTHPA, and CA (36, 76, 118, 120, 127, 134, 136, 160, 164, 176, 192, 193, 195,
201, 216). The induction time for positive specific IgE antibodies has been 8.8
(range 1-35) months when HHPA-, MHHPA-, and MTHPA-exposed workers
were followed. The incidence of sensitisation was 4.1 cases/1 000 months at risk
(193). The half time for specific IgE antibodies after cessation of the exposure
was 1 year for TCPA and 0.9 year for MTHPA (186, 191). Commercial tests are
available for measuring specific IgE antibodies for some anhydrides (123).
Inhibition studies and passive transfer studies have supported the specificity of
IgE antibodies. However, cross-reactivity between some acid anhydrides has been
reported (36, 119, 176, 190).
Immediate-type skin tests with acid anhydride-HSA conjugate have correlated
well with the finding of specific IgE (17, 76, 143, 190, 192, 193, 216).
The location and specificity of the IgE antibody for the epitopes present on the
acid anhydride (hapten)protein complex have been studied. It has been postulated
that the reaction of acid anhydride with albumin alters the albumin to form a new
antigenic determinant or that the hapten is altered at the antibody-combining site
(19, 143, 210, 216). The formation of new antigenic determinants on the albumin
site explains the cross-reactivity in the radioallergosorbent tests (RAST). There is
evidence that in patients sensitised to TCPA and TMA, the antibody combines
with the anhydride and the adjacent portion of the HSA molecule, whereas in
patients sensitised to PA, the antibody is specific to the hapten (176). TMA is
claimed to form unique antigenic determinants that do not bind significantly with
antibodies formed by sensitisation to PA, HHPA and HA. This may explain why
significant cross-reactivity with TMA has not been found in inhibition studies (19,
176, 216).
The workers exposed to either MTHPA or both HHPA and MHHPA have
showed a marked cross-reactivity in skin prick tests, in the specific IgE deter-
minations as well as in inhibition studies to MTHPA-HSA, HHPA-HSA, and
MHHPA-HSA but not to PA-HSA and MA-HSA. For PA-exposed subjects the
cross reactivity with other anhydrides was less pronounced (190).
The serum levels of specific IgE antibodies and interleukin-4 and interleukin-13
as Th2 lymphocyte markers and interferon-gamma as a Th1 lymphocyte marker
were measured in 147 MTHPA-exposed workers. Work-related eye and nasal
symptoms due to MTHPA were associated to the levels of interleukin-4 and also
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interleukin-13. A shift in the balance between Th1 and Th2 cells was suspected due
to the IgE mediated allergic response (204).
Specific IgG antibodies have been studied especially in connection with
sensitisation to TMA. Specific IgG antibodies against TMA-HSA have been
correlated with late-onset occupational asthma due to TMA. They have also been
found in the pulmonary disease-anaemia syndrome due to TMA, as have IgG
antibodies to erythrocyte conjugate (142, 144, 145, 164, 177).
Specific PA-IgG antibodies have been found in a worker exposed to PVC
degradation products and phthalic acid esters. This finding indicates exposure to
phthalic anhydride (131).
No cross-reactivity with PA, MA, HHPA, or TCPA was found when the
specificity of IgG antibodies against TMA-HSA conjugate was investigated. In
an equal test TMA-HSA was able to inhibit IgG bound to both PA-HSA and
MA-HSA. Another antibody was suspected (53).
Nielsen and his co-workers have studied IgE, IgG, IgG4, and IgM antibodies
specific for PA in workers from alkyd or unsaturated polyester resin production.
The mean level of exposure was 6 600 (1 500-17 400) µg/m3 (time-weighted
average, TWA) during loading and for full workday 400 µg/m3. Of the heavily
exposed workers, 69% had rhinitis and/or conjunctivitis and 5 workers (14%) had
PA-induced asthma. There was a significant (p=0.01) difference between the
heavy and low exposure groups only for specific IgG against PA. Only 1 worker
with asthma had an increased specific IgE level. The subjects with asthma had
significantly higher values for specific IgG than the asymptomatic subjects.
Specific IgG4 was found in 4 persons, 3 had asthma and 1 had rhinitis. The
authors concluded that specific IgG is an index of PA exposure, and that specific
IgG4 may be a pathogenetic factor in asthma (136).
In TMA-exposed workers, the levels of IgG1-4 subclasses against TMA-HSA
did not differ between workers with and without a TMA-induced immunological
lung disease (52).
In MTHPA-exposed workers no association between work-related symptoms
and specific IgG4 antibodies was found, but the intensity of the exposure was the
major determinant of specific IgG4 levels (201, 205).
Reports of allergic occupational diseases due to cyclic anhydrides: PA
Wernfors et al. studied 118 workers in four plants producing alkyd or unsatu-
rated polyester resins. Forty-eight were current employees and 70 were former
employees. The PA dust concentrations during the loading of the reactors and in
the handling of bags were very high, up to 13 000 µg/m3. The fraction of
respirable dust was about 40%. The authors found 28 (24%) persons with work-
related rhinitis and 21 (18%) with asthma. Eleven per cent had symptoms of
chronic bronchitis. In 10 of the 21 asthmatics, rhinitis preceded the asthmatic
symptoms. The latency period before the onset of the respiratory symptoms
ranged from 1 month-16 year. A positive skin-scratch test was found in 3 of the
11 asthmatics but in none of the non-asthmatics. A Prauznitz -Küstner test was
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positive with serum of 2 asthmatics. The same patients were challenge tested. The
bronchial provocation tests with PA powder 6 000 µg/m3 (5 minutes) caused a
dual asthmatic reaction in the first patient, whereas the test with 500 µg/m3 was
negative. The second patient experienced a dual reaction when challenged with
the lower PA concentration (196).
When the exposure level of PA was measured (Table 11), the full day TWA for
PA was approximately 400 µg/m3, well below the Swedish exposure limit value
6 000 µg/m3 at that time. The authors then suggested a ceiling value below 6 000
µg/m3 for PA (136).
Reports of allergic occupational diseases due to cyclic anhydrides: TMA
Both immediate- and late-type respiratory allergies have been reported due to
TMA. Both begin after a latency period. Specific IgE antibodies have been found
in immediate-type rhinitis and asthma (144, 214). In the late-type respiratory
syndrome the worker experiences coughing, wheezing and dyspnoea, starting 4-8
hours after the exposure. The respiratory symptoms have been accompanied by
malaise, chills, fever, myalgia and arthralgia. No specific IgE antibodies are
found, but IgG and IgA antibodies are present (144, 214). The disease has not
been verified with challenge tests. An irritant reaction has been postulated (183).
Pulmonary disease-anaemia syndrome due to TMA is a disease first reported by
Rice et al. in 1977. Herbert and Orford reported 7 more cases in 1979, and Ahmad
et al. presented another 2 in 1979. All cases had been exposed to fumes from
TMA-cured epoxy resin sprayed on hot pipes. The symptoms were cough,
haemoptysis, dyspnoea, pulmonary infiltrates, restrictive respiratory defect,
hypoxaemia, and anaemia. The symptoms ranged from mild to very severe. A
possible fatal case was identified (2, 74, 142, 157). IgG antibodies have been
found to both human serum conjugate and erythrocyte conjugate of TMA. Open
lung biopsy has shown intact alveolar septae and extensive intra-alveolar
haemorrhage with granular pneumocyte hyperplasia. Immunofluorescent studies
were negative, suggesting that the antibodies were not involved in the tissue injury
(2, 74, 144, 157, 214). Patterson et al. did not find any IgE antibody activity
against trimellityl-HSA (TM-HSA) in workers with pulmonary disease-anaemia
syndrome. IgG activity against TM-HSA did not differ from the level in other
workers exposed to TMA fumes under similar work conditions. IgG, IgA and IgM
antibodies were found against TMA-human erythrocytes (142). Later, antibodies
to TMA-human erythrocytes were also found in workers with asthma due to
TMA, but not in unexposed persons (177).
All 9 workers from a barrel manufacturing plant were investigated because of
their exposure to TMA. The levels of TMA in the personal breathing zone were
1 700-3 600 µg/m3. One worker was asymptomatic. Four workers had TMA-
induced irritant effects. Three had symptoms and IgG levels consistent with late-
type respiratory syndrome. One of them also had specific IgE against TMA. One
worker had bronchitis not related to TMA (109).
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In a factory preparing epoxy resin coating material the exposure level for TMA
was less than 180 µg/m3 after improvements in work hygiene. During two years
no TMA related diseases were found among 11 workers (124).
In the TMA manufacturing industry, a 12-year (1976-1987) clinical and
immunological evaluation of 196 workers was carried out. The diagnosis was
based on results of a questionnaire, an interview and immunological studies for
total TMA antibodies and TMA-specific IgE. IgE-mediated immediate-type
asthma or rhinitis was found in 21 workers and late-type asthma in 10 workers,
and yet another worker had pulmonary disease-anaemia syndrome. A total of 113
workers had only irritant symptoms, and 46 were asymptomatic. A low level of
total antibodies was found for TMA-HSA in 16% and 8%, respectively. No data
were available on the exposure. There was, however, an annual decline in the
number of sensitised workers due to improvements at the workplace (212).
In the same factory, in a cross-sectional study of 474 workers in 1988-1989
with a very similar setting, five exposure groups were assigned by an industrial
hygienist on the basis of job history and the results of personal monitoring of
some employees in each exposure class. Seven per cent had an immunological
syndrome due to TMA exposure, and 32% had irritant symptoms with low
specific total and IgE antibody levels. Sixty-two per cent had no work-related
symptoms and very few or no antibodies. The mean total antibody levels and
mean IgE antibody levels decreased according to the exposure level. TMA
specific IgE antibodies were found only in the high exposure group (0.54-6 500
µg/m3, geometric mean 170 µg/m3) whereas the findings were negative in four
other groups with exposure less than 6-970 µg/m3 (geometric mean 87 µg/m3) of
TMA. The sensitisations and illnesses due to TMA were concentrated into the
three upper exposure groups, and therefore efforts to reduce exposure were
suggested. A group of new employees not evaluated earlier for an occupational
disease were analysed for total TMA-HSA antibody levels by age, sex, date of
hire and smoking. Only current or former smoking was associated with the total
antibody levels (χ2=6.45, p=0.01). Atopic status was not assessed (213). One year
after 29 sensitised workers had been moved to low-exposure jobs, their symptoms
and pulmonary functions had improved and the specific antibody levels had
decreased (60).
One case of allergic alveolitis has been reported in connection with exposure to
both TMA and PA. The worker was exposed to the dust and fumes of polyester
powder paint during a malfunction of the ventilation of the factory hall. The paint
contained small amounts (<1%) of both TMA and PA. The diagnosis was based
on the follow-up of the symptoms and on the findings in chest radiographs and
BAL, as well as on the presence of fever and a slight reduction in the transfer
factor after a short re-exposure at work (153).
Reports of allergic occupational diseases due to cyclic anhydrides: MA
Durham reported in 1987 the results of the MA challenge tests of 2 MA-exposed
workers (a storeman and a batch weigher). In both cases control tests were
negative and dual asthma reactions due to MA were verified (37). In another
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report a worker developed cough, rhinitis, breathlessness and wheezing after one
month of exposure to PA and MA. The dust exposure during the emptying of
bags was 330 µg/m3 for PA and 170 µg/m3 for MA. The worker was a smoker.
An atopic tendency was found in the skin prick tests, and he had nonspecific
bronchial hyperreactivity. In the bronchial challenge tests with MA crystals he
experienced a dual asthmatic reaction, whereas the test with PA was negative. The
dust concentrations were well below those measured from the workplace. No skin
prick tests or antibody determinations were carried out (108).
A worker in MA production who had previously had MA-related asthmatic
symptoms developed severe haemolytic anaemia. He relapsed two weeks after the
return to work the next year. Afterwards he remained stable as long as he avoided
MA exposure. He had high titre of MA-specific IgE but not IgG antibodies. The
Coombs test was positive but no antibodies to MA red-cell conjugate were found.
There were no symptoms of pulmonary haemorrhage in conjunction with
pulmonary disease-anaemia syndrome due to TMA exposure (50, 81).
Reports of allergic occupational diseases due to cyclic anhydrides: HHPA
In 1985 Moller reported the first cases of occupational sensitisation to HHPA
from exposure to epoxy resin moulding. Twenty-seven workers were evaluated on
the basis of the results of a questionnaire, pulmonary function tests, and antibody
determinations. The concentration of HHPA was very high when compared to the
more recent studies (Table 11). All 4 cases with symptoms of occupational asthma
had specific IgE to HHPA conjugates, as did 6 of 22 cases with rhinitis and/or
conjunctivitis. In the specificity studies both HHPA-HSA and PA-HSA were
effective inhibitors (127).
Erosions of the nasal mucosa and epistaxis have been described in connection
with IgE-positive occupational rhinitis due to HHPA. All the patients also had
high titres of specific IgG. The HHPA concentration was not determined, but it
was not considered high enough to cause tissue destruction (61). The same group
followed 28 employees with HHPA-induced asthma or rhinitis for least one year
after removal from exposure. The symptoms and spirometry normalised in all but
1 worker. There was a decline in the HHPA-specific IgE in 25 workers (59).
Chee et al. diagnosed a case of asthma due to HHPA in the manufacture of
epoxy resins. The hardener consisted mainly of HHPA but also of an amine as an
additive. In the process the hardener was heated to 130°C. The long-term follow-
up of peak expiratory flow showed deterioration during the workweek and
improvement during days off. The authors also carried out challenge tests. A
control test where an empty tin was heated was negative. When 200 ml of pure
HHPA was heated to 92°C, the patient experienced a severe immediate and also a
late long-lasting asthmatic reaction. No skin prick tests or antibody determinations
were carried out (26).
Nielsen et al. investigated the allergic aetiology of work-related nasal
symptoms of HHPA-exposed workers. Nasal challenge tests with HHPA-HSA
conjugate were carried out. The results were positive in 11 subjects sensitised to
HHPA (positive skin prick tests and specific IgE antibodies) and negative in 9
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non-sensitised subjects, in spite of work related irritation symptoms in the non-
sensitised individuals (135).
Reports of allergic occupational diseases due to cyclic anhydrides: MHHPA
MHHPA has caused sensitisation and respiratory symptoms (96). A rare case of
specific MHHPA-induced laryngitis has been reported in an electrician. A skin
prick test with MHHPA conjugate was positive, and specific IgE antibodies to the
conjugate were found. The laryngeal reaction was verified by a challenge test with
MHHPA (163).
Reports of allergic occupational diseases due to cyclic anhydrides: MTHPA
Nielsen et al. found a case of work-associated asthma and rhinitis in a subject
exposed to MTHPA used as an epoxy-curing agent in the preparation of barrels
for grenade firearms. MTHPA-HSA-specific IgE antibodies were found, but
specific IgG antibodies were not present. A skin prick test was positive with the
same conjugate but negative with PA-HSA (137). Later the work force of the
factory was examined for symptoms, exposure, antibody response, lung functions
and risk factors. In a group consisting of 140 currently and 26 formerly exposed
workers, they found higher frequencies of work-related symptoms of the eyes (31
versus 0%), nose (53 versus 9%), pharynx (26 versus 6%) and asthma (11 versus
0%) than among 33 controls. The rate was 16 for positive skin prick tests with
MTHPA-HSA conjugate, 18 for specific IgE antibodies and 12 for specific IgG
antibodies, while for the controls all the tests were negative. There were statisti-
cally significant exposure-response relationships between the exposure and
symptoms of the eyes and upper airways, dry cough, positive skin prick tests and
specific IgE and IgG antibodies. The concentration of MTHPA was under 150
µg/m3. The median exposure time for specific IgE positivity was 5 (range 0.2-5)
years. A close association between specific IgG4 and total specific IgG was found.
Up to 91-95% inhibition of the IgE-MTHPA-HSA binding was reached with
MTHPA. There were no significant differences in lung functions between
sensitised and non-sensitised subjects. No association between sensitisation and
either atopy or smoking was found. They found that significantly more former
workers than current ones had positive skin prick tests with common allergens;
atopic workers tended to withdraw from the exposure early, perhaps even before
clear work-related symptoms appeared (133, 134, 192).
The decline in serum antibodies to MTHPA was followed in 10 workers after
the cessation of exposure an average of 54 months earlier. The mean individual
half-time for specific IgE was 0.9 years, and for specific IgG it was 0.4 years. In
addition, 4 workers who moved to jobs with significantly reduced exposure were
followed, and corresponding decreases in antibodies were seen. No correlation
was found between the half-times of specific IgE and total IgE, atopy, smoking or
gender (191).
Yokota et al. studied the workers at two plants where condensers for electric
appliances were manufactured and MTHPA was used as a hardener in the epoxy
resin insulation. Some workers had had work-related nasal symptoms. At first the
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authors studied 28 workers exposed to MTHPA levels between 1.09 and 22.4
µg/m3. Specific IgE antibodies were detected in 9 (32%) of the workers. Eight of
them had nasal symptoms. The authors also found that the total IgE levels were
significantly higher in the group with specific IgE, and suggested that total IgE
can be used in the selection of workers (199).
A later study group consisted of 148 workers, of whom 66% had specific IgE
antibodies. The authors further found that the relative risk for elevated MTHPA-
specific IgE for smoking was 4.1. In the group with a high total IgE, the relative
risk of producing IgE antibodies to MTHPA was 4.7 in a comparison with the
group with a low total IgE (<80 IU/ml) (200).
In a study of the exposure-response relationship, the minimal level for an
association between MTHPA exposure and work-related symptoms was 15-22
µg/m3. It was suggested that exposure above 15 µg/m3 should be avoided to
prevent the development of occupational allergic diseases among most workers
(202).
In 1991, Drexler et al. investigated 110 workers exposed to HHPA and
MTHPA and found that 20 of them were sensitised according to skin prick tests
and specific IgE determination. In challenge tests occupational asthma or rhinitis
was verified for 6 cases. The concentrations of acid anhydrides in air were not
measured. In the end of 1991 the hygienic conditions at the plant were improved.
In 1995 a new study was carried out that also included people who had left the
plant since 1991. The relative risk of people sensitised in 1991 leaving the plant
between 1991 and 1995 was 2.6 compared with people without any sign of
sensitisation. The rate of sensitisation was 21%. None of the 6 persons employed
after 1991 showed evidence of sensitisation. Five of the 6 persons with verified
sensitisation in 1991 were still at the workplace. All of them reported fewer
symptoms than before. The exposure level was measured in 1995, and it was
<0.5-36 µg/m3 (35, 36).
Reports of allergic occupational diseases due to cyclic anhydrides: TCPA
In 1987 five cases of occupational asthma due to TCPA in epoxy resin were
reported. The diagnoses were confirmed in 3 workers by dual asthmatic reactions
in inhalation challenge tests. TCPA-bovine serum albumin conjugate was used to
detect specific IgE antibodies. No antibodies were found (168).
TPCA has been used as an epoxy-resin curing agent since 1979 in an epoxy-
coating process in a factory making electronic components in the United
Kingdom. Seven cases of occupational asthma were diagnosed in 1979-1980.
Inhalation challenge tests with controlled TPCA concentrations from 1.3-961.1
µg/m3 with both immediate and late reactions confirmed the diagnoses. Specific
skin prick tests were positive, and specific IgE antibodies against TCPA-HSA
conjugate were detected. The factory was closed in 1980 (76, 184). A 12-year
follow-up showed that symptoms at first improved, but then remained unchanged.
All the cases still had daily or weekly symptoms. The bronchial hyperresponsive-
ness had also persisted. Specific IgE antibodies fell slowly with a half-time of
1 year (12, 186).
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In a Canadian cross-sectional study of 56 workers in a factory using TCPA-
cured epoxy resin for about 2 years, the prevalence of work-related respiratory
symptoms was high, 27-39%. According to a questionnaire, occupational asthma
was present in 35% of the workers. Thirty-one per cent had specific IgE, and
39% had specific IgG against TCPA-HSA. The mean TCPA concentration was
between 210-390 µg/m3. The prevalence of specific IgE was highest among those
who had the jobs with the highest exposure. After the ventilation was improved
and exposure was reduced to less than 110 µg/m3, the symptoms decreased, and
no new cases of occupational asthma were found (118).
Reports of allergic occupational diseases due to cyclic anhydrides: PMDA
In 1980, Meadway reported 2 cases of asthma from exposure to PMDA-cured
epoxy resin when glue was mixed, used and cured. The workers underwent
challenge tests simulating work with the mixture, and the results were positive.
Five other workers had negative test (125).
Next report on PMDA is from year 1995. A cross-sectional and follow-up study
was carried out with 92 workers with exposure mainly to PDMA but also to PA,
MA or TMA. Of those with less than one year of exposure, 56 workers had work-
related symptoms. Eighteen had dyspnoea, and 8 had bronchial obstruction.
Specific IgE antibodies were found only in 15 workers, of them 12 had symptoms.
The authors also found 11 cases of haemorrhagic rhinitis that occurred after more
than 15 years of exposure. Only one of the cases had specific IgE antibodies.
After 10 months both the symptoms and the bronchial obstruction of the group no
longer exposed had diminished, whereas the workers still exposed had comparable
pathological findings in the re-examination. The symptoms were reversible in
workers whose exposure stopped after a work period of about 0.7 years. No
relevant specific IgG antibodies were detected in this group (18).
A case of acute haemorrhagic alveolitis associated with anaemia similar to
pulmonary disease-anaemia syndrome due to TMA has been reported for PMDA
exposure. PMDA in powder form was used as a cross-linking agent in epoxy
resin production. High concentrations of PMDA-specific IgG antibodies were
found and also TMA-specific IgG antibodies, but not PA- or MA-specific IgG
antibodies. The patient had no specific IgE antibodies. The Coombs test was
negative (29).
Reports of allergic occupational diseases due to cyclic anhydrides: HA
A worker exposed to HA powder in the manufacture of a synthetic flame retardant
developed after one year rhinitis, hives, and wheezing at work. He and 2 of the
6 other symptomatic workers of all 20 tested had specific IgE antibodies for
HA-HSA conjugate. In RAST inhibition studies HA-HSA showed the highest
inhibition. A cross-reactivity was found with HHPA-HSA but not with PA and
TMA conjugates (160).
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Reports of allergic occupational diseases due to cyclic anhydrides: CA
A welder developed work-related urticaria and asthmatic symptoms when exposed
to the thermal degradation fumes from a polyester paint. The paint contained both
alkyd resins and chlorinated polyester resin. A new sensitising anhydride, CA,
was identified from the hardener. A skin prick test with CA-HSA conjugate was
positive, as was an open test for urticaria. CA-HSA-specific IgE antibodies were
also detected. Significant decreases in peak expiratory flow measurements were
seen after short (10 seconds) welding procedures (102).
Concluding remarks
The reports of occupational asthma and rhinitis due to PA are mainly dated to the
years 1980-1990. The case reports and industrial surveys on TMA-induced work-
related respiratory symptoms are likewise not very recent. During last decade
MTHPA and HHPA have been the main topics of concern. The exposure levels
have decreased with improved work hygienic control, but exposure peaks still
occur.
The respiratory allergies have mainly been IgE mediated. Specific IgE antibody
determinations and skin prick tests are relevant methods when investigating the
aetiology of work-related symptoms. Specific IgE antibodies cannot, however, be
used to assess exposure at the work place. The half-time of specific IgE antibodies
after cessation of the exposure has been about 1 year.
The 12-year follow-up study of TCPA-induced asthma showed a poor pro-
gnosis for occupational asthma despite cessation of the exposure. Equally long
follow-up studies are not available on occupational asthma induced by other
cyclic acid anhydrides.
11.2.3 Predisposing factors for cyclic acid anhydride-related allergy
Venables and co-workers studied the effect of smoking and atopy on antibody E
production in 300 TCPA-exposed workers. Atopy was defined as at least one
positive skin prick test to common allergens. Twenty-four of the workers had
specific IgE to TCPA. Twenty of them (83.3%) were current smokers compared
with 133 (48.2%) of 276 without antibodies (p<0.01). Atopy was also more
common in those with specific IgE, but not significantly so. Smoking and atopy
interacted, the prevalence of antibody being 16.1% for atopic smokers, 11.7% for
nonatopic smokers, and 8.3% for atopic non-smokers (p>0.025). The authors
concluded that smoking may interact with atopy in the production of specific-IgE
antibodies to TCPA (185).
In a study of 55 workers highly exposed to MTHPA no significant differences
were found between the subgroups for atopy and smoking habits according to IgE
sensitisation. In the same study with a total of 144 exposed workers the group of
former workers had positive skin prick tests to common allergens significantly
more often than unexposed controls. The authors suggested that atopic workers
tend to withdraw from exposure early because their mucous membranes are more
reactive and therefore atopic persons do not seem to run a particular risk of
sensitisation to small reactive organic molecules (134).
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In a recent prospective study, 163 workers exposed to HHPA, MHHPA and
MTHPA were followed for 32 (1-105) months. The mean combined exposure
level was 15 (range <1-189) µg/m3. Thirteen per cent of the workers had positive
specific IgE. An association was found between exposure and atopy, respectively,
and the induction of specific antibodies. The odds ratio for atopics to get IgE
sensitised as compared with non-atopics was 6.0 (95%CI 2.2-16.6). Subjects with
a mean exposure of >15 µg/m3 had a significantly higher risk for development of
specific IgE (odds ratio 3.4; 95%CI 1.2-9.4) than subjects with a mean exposure
of <10 µg/m3. The risk for atopics was comparable with the risk for the subjects in
the most exposed group. The effect of smoking was not significant (193).
In a Canadian study of 148 MTHPA-exposed workers a correlation was found
between total IgE and specific IgE (p<0.0001). Current smoking was significantly
associated with specific IgE production only in the group with low total IgE, <100
kU/ml (200).
Altogether 119 TMA-exposed workers were followed for five years to
determine whether they would develop a respiratory disease. Sixteen had TMA-
specific IgE antibodies and 3 of them had asthma in the beginning. Another 6
developed asthma during the 5-year follow-up period. One of the 102 workers
with no specific IgE antibodies developed asthma. Specific IgG antibodies were
detected in 44 subjects, 6 had a non-immediate respiratory disease in the
beginning and 2 more were found after five years. None of the IgG-negative
workers developed a respiratory disease (58). In a study of 57 HHPA-exposed
workers, 7 had IgE and IgG-mediated respiratory disease whereas 9 had only
IgE-mediated disease. An association was found between the development of
respiratory disease and specific IgE and IgG antibodies, as well as an association
with the level of exposure but not with smoking (62). Skin prick test reactivity to
common allergens in 33 employees with respiratory symptoms due to HHPA
showed that atopy had only a marginal clinical significance as a risk factor for
disease (63).
In a case-control study of 16 persons with TMA asthma and 44 similarly
exposed controls, determinations of specific IgE against four common environ-
mental allergens were carried out. Fifty-six per cent of the cases and only 29% of
the controls were found to be atopic (172).
Risk factors for sensitisation and respiratory symptoms were evaluated in a
historical cohort study consisting of 506 workers from four factories. The cohort
was defined as all workers with exposure to anhydrides for more than one month
since the beginning in 1960. Three factories manufacturing resins used principally
PA, but also MA and TMA were used. One factory produced cushioned flooring
and used only TMA. The exposure was assessed retrospectively, by job. The
current full-shift and task-specific exposure measurements, the past exposure data
and qualitative information were used and exposure estimates were calculated in
the job-time-exposure matrices (181). The questionnaire, comprising employment
history, respiratory symptoms and smoking habits, was completed by 401 workers
(79%). Skin prick tests with common inhalant allergens and anhydride conjugates
were carried out. Thirty-four persons (8.8%) had respiratory symptoms related to
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anhydride exposure, and 12 (3.2%) were sensitised according to the skin prick
tests with anhydride conjugates. Sensitisation was associated with work-related
respiratory symptoms and with smoking, at the time of the exposure to acid
anhydride. An exposure-response relationship was not found overall, but in the
factory with exposure to TMA an increased prevalence of sensitisation and work-
related symptoms with increasing full-shift exposure:<10, 10-40 µg/m3 and >40
µg/m3 of TMA was observed. The relation was apparent within the current
occupational exposure standard of 40 µg/m3 and it was not modified significantly
by smoking or atopy. Exposure to PA or MA was found to be uncommon as a
cause of sensitisation at the low exposure levels measured, 8.9-11.9 µg/m3 and
1.8-2.8 µg/m3, respectively (13).
The association of human leukocyte antigen (HLA) allele frequency and
specific IgE antibody to acid anhydride-HSA conjugates has been investigated to
determine a possible genetic influence on sensitisation. Thirty workers with work-
related respiratory symptoms with specific IgE antibodies had been exposed to
PA, TMA, or TCPA. Thirty referents were exposed to PA or TMA. A similar
proportion of both the cases and referents were atopic and smokers, the other risk
factors for this sensitisation. A significant excess of HLA-DR3 loci were found in
cases with specific IgE to acid anhydrides when compared with the controls (50%
versus 14%). A relationship was found between HLA-DR3 and specific IgE
antibodies for TMA and possibly for TCPA but not for PA. The difference in the
epitope was suggested as the reason for the different findings (206).
Altogether 57 HLA antigens were analysed in MTHPA- or HHPA-exposed
workers. Fifty-three were sensitised according to the specific IgE antibodies and
positive skin prick test. Forty-seven non-sensitised exposed workers were
controls, as was a group of unexposed subjects. Only for HLA-A25 and HLA-A32
statistically significant differences were found between the sensitised and non-
sensitised workers, 0% versus 9% and 0% versus 13%, respectively. An HLA-
antigen-associated immune protective factor was suspected to reduce the risk of
sensitisation. An association HLA-DR3 was not found for MTHPA-sensitised
workers, as in an earlier study on TMA-sensitised workers (132).
Concluding remarks
In TCPA-exposed workers smoking and atopy have been found to interact in the
production of specific-IgE antibody to TCPA. In a prospective study on HHPA-,
MHHPA- and MTHPA-exposed workers, a significant effect of atopy, as well as
of exposure, on sensitisation was observed. The influence of smoking on
sensitisation was not significant.
The influence of smoking and atopy on TMA sensitisation has been non-
significant. Increasing full-shift exposure to TMA has been a predisposing factor
for sensitisation.
There are also two studies on the genetic background of sensitised persons. A
relationship was found between HLA-DR3 and specific IgE antibodies for TMA
and possibly for TCPA but not for PA. When MTHPA- and HHPA- exposed
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workers were investigated no such association was found but an HLA-A25 and
HLA-A32 associated immunoprotective factor was suspected.
11.3 Genotoxic effects
There are no data on genotoxic effects of cyclic acid anhydrides in humans.
11.4 Carcinogenic effects
In a case-control study mortality from lung cancer was investigated in a plant
producing acetylene and PA. After control for age and smoking, the odds ratio
for lung cancer mortality among the 43 subjects exposed in the factory was 5.6
(95%CI 1.9-16.2). The corresponding odds ratio for 99 referents from other work
environments in the region was 1.7 (95%CI 0.9-3.5). There was, however,
exposure also to phthalates and soot (156).
11.5. Reproductive and developmental effects
There are no data on the developmental effects of cyclic acid anhydrides on
human reproduction.
12. Dose-effect and dose-response relationships
12.1. Single and short-term exposures
The acute effects of cyclic anhydrides on animals have generally been found to
be irritation of mucous membranes after direct exposure (Table 7).
The human nasal irritation threshold for PA has been reported to be 30 000
µg/m3 and that for MA to be 5 480 µg/m3 (162). However, exposure type and
duration, generation of anhydrides, and particle sizes were not given. In early
reports, irritation of the mucous membranes was a common immediate response
in workers highly exposed to acid anhydrides in powder form (11, 126, 136). In
workers exposed to high levels of TMA, rhinorrhoea, cough, and dyspnoea have
been reported already after the first exposure (214). In more recent studies irritant
symptoms of eyes and upper airways have been detected after relatively low
exposure (150 µg/m3 TWA) of MTHPA (134).
Immunisation of animal species verified with specific IgE and IgG antibodies,
followed after cutaneous administration or single intradermal injection with free
or conjugated PA, TMA, MA, HHPA, MHHPA, MTHPA, THPA and SA (Table
7 and 8). Repeated short-term exposures (subcutaneous or inhalation) with PA or
the corresponding conjugate induced specific IgG antibody formation in a dose-
response manner in guinea pigs. In challenges after sensitisation, more positive
tests were seen when a higher dose was used (165) (Table 8).
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In inhalation challenge tests in rats, concentrations of 30-300 µg/m3 of TMA
dust induced haemorrhagic lung lesion and antibodies, whereas 10 µg/m3 had no
effects (211).
12.2 Long-term exposure
Long-term dose-response studies (animals) are few. Rats, hamsters and monkeys
were exposed to 1 100-9 800 µg/m3 concentrations of MA 6 hours/day 5 days/
week for 6 months. Nasal and ocular irritation and metaplasia of nasal mucosa
were found at all the exposure levels only in rodents being obligate nose breathers
(171).
Human data derived from industrial surveys have been compiled in Tables 10
and 11.
In a survey with a total exposure time of about 40 years, 46% in the high
exposure group (1 500-17 400 µg/m3 of PA) had conjunctivitis, 40% had rhinitis,
and 14% had asthma. In the low exposure group (<100 µg/m3) the corresponding
figures were 20% for conjunctivitis and rhinitis, and 0% for asthma. There was no
association between specific IgE antibodies and PA exposure (136).
In a historical cohort study of PA- and MA-exposed workers sensitisation was
found to be uncommon at the low exposure levels measured, 8.9-11.9 µg/m3 and
1.8-2.8 µg/m3, respectively (13).
When TCPA had been in use for two years, 35% of the 56 exposed workers
had occupational asthma according to a questionnaire, and 31% had specific
IgE antibodies. The exposure levels to TCPA in preforming and moulding had
been between 140-590 µg/m3. The next year, after the ventilation was improved,
the TCPA exposure fell to 30 µg/m3 in preforming and to <10-110 µg/m3 in
moulding. After that, work-related symptoms decreased and no new cases of
occupational asthma have been reported (118).
In a historical cohort study of TMA-exposed workers, the prevalence of
sensitisation and work-related symptoms increased with increasing exposure. In
workers exposed to 10-40 µg/m3 or >40 µg/m3 of TMA compared to the workers
exposed to <10 µg/m3, the odds ratio for positivity was for TMA skin prick tests
10.0 and 20.7 and for the risk of new work-related respiratory symptoms 5.9 and
7.4, respectively (13).
In workers exposed to HHPA and MHHPA at levels of <10, 10-50 and >50
µg/m3 specific IgE antibodies were found. There were no differences in levels of
the specific IgE antibodies between the exposure groups. The workers in the low
exposure group had, however, occasionally had higher exposure peaks (195).
Among MTHPA-exposed workers, even at low levels of exposure (5-20 µg/m3)
56% had symptoms of the eyes and upper airways, 9% had asthma, and 16% had
MTHPA specific IgE antibodies. The corresponding numbers were 65%, 11%,
and 22% in the more heavily (20-150 µg/m3) exposed groups (134, 192).
When HHPA- and MHHPA-exposed workers were followed for a mean
period of 33 months (range 1-85), 27% had been sensitised and had specific IgE
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antibodies. Altogether 21.6% had positive reactions in skin prick tests with
corresponding HSA-conjugates. The exposure level was 38.7 (range 1-187)
µg/m3. In workers exposed to MTHPA at levels 10.1 (range 9-38) and 5.9 (range
0-50) µg/m3 the percentage of positivity for specific IgE antibodies were 8.6%
and 8.9% and for skin prick tests 4.9% and 2.2%, respectively. The observation
times were 26 (range 2-38) and 40 (range 1-105) months. There was no
statistically significant difference between peak exposure levels in sensitised and
nonsensitised workers in these studies (193).
Concluding remarks
Immunisation has been induced by a single intradermal dose of various cyclic
anhydrides in animals. Exposure to high as well as low levels has without any
latency period caused irritant symptoms in workers. Metaplasia of nasal mucosa
has been seen in animals after long-term exposure to high levels of MA. The data
on dose-response of sensitisation, and work-related symptoms are too limited for
determining any lowest observable adverse effect level, but in industrial surveys
TCPA and PA have induced sensitisation and asthma in workers exposed to the
concentrations 140 and 1 500 µg/m3, respectively. TMA, HHPA, MHHPA, and
MTHPA have caused both sensitisation and work-related symptoms at exposure
levels as low as 5-50 µg/m3.
13. Previous evaluations by national and international bodies
The documentation of the American Conference of Governmental Industrial
Hygienists (ACGIH) was revised for PA in 2000, for TMA in 1993 and for MA in
2000. PA was defined as an irritant and sensitiser of the skin and respiratory tract
and potent ocular irritant. The potency of irritancy was considered lower than that
of MA. TMA was defined as irritant to the respiratory tract, the eyes, and skin and
also as sensitiser in repeated exposure. To prevent sensitisation, a ceiling value
was recommended in 1993. MA was defined as an irritant of the skin, eyes and
upper respiratory tract, and as a sensitiser of the respiratory tract. According to
ACGIH, PA and MA are not classifiable as human carcinogens (1).
The Health and Safety Executive (HSE) in the United Kingdom published a
document on three acid anhydrides in 1996 (PA, TMA, and MA). The principal
adverse effects of exposure in humans were stated to be asthma and respiratory
tract irritancy and, for TMA, also other respiratory effects, which may be accom-
panied by systemic toxicity. Asthma was regarded as a serious health effect, and
therefore the assignment of maximum exposure limits was indicated for each
substance. A special notation of the respiratory sensitisation properties of each
substance was added (158).
SA has been evaluated by the International Agency for Research on Cancer
(IARC); limited evidence of a carcinogenic effect was reported for animals, but
SA was not classifiable as carcinogen in humans (group 3) (78).
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Chlorendic acid, the hydrolysis product of CA, has been evaluated by IARC.
The evidence was sufficient for the carcinogenicity of chlorendic acid in experi-
mental animals. There are no data on its carcinogenicity in humans, but, overall, it
was concluded that chlorendic acid is possibly carcinogenic to humans (Group
2B) (79). In the evaluation of the International Programme on Chemical Safety
(IPCS), separate carcinogenicity studies with CA were not considered necessary,
since the compound is metabolically transformed to chlorendic acid (80).
In the European Union commission directives on the approximation of the laws,
regulations and administrative provisions relating to the classification, packaging
and labelling of dangerous substances, PA, TMA, MA, HHPA, MHHPA,
MTHPA, THPA, TCPA, HA and PMDA have been classified as sensitisers by
inhalation and skin contact (39, 40). All of them have also been classified as
irritants. In addition, PA and MA have been classified as harmful when swallowed
because of the acute toxicity in animal studies. No occupational exposure limits
for cyclic acid anhydrides have been set by the European Union.
14. Evaluation of human health risk
14.1 Groups at extra risk
When TCPA-exposed workers were investigated, smoking was found to interact
with atopy in the production of specific IgE antibodies (185). On the other hand
in a historical cohort study of TMA-exposed workers, there was an increased
prevalence of sensitisation and work-related symptoms with increasing exposure
but not with smoking or atopy (13). In another study, smoking was associated
with specific IgE production to MTHPA only when the total IgE was low (200).
In a prospective study of HHPA-, MHHPA-, and MTHPA-exposed workers an
association was found between atopy and specific IgE antibodies. The effect of
smoking was not significant (193).
In conclusion, atopy seems to predispose for sensitisation against cyclic acid
anhydrides whereas no conclusion can be drawn with respect to smoking.
14.2 Assessment of health risk
The most common symptom from exposure to cyclic acid anhydrides is irritation
of the mucous membranes (Tables 7 and 8). In long-term animal studies with MA,
metaplasia of nasal tissue has been developed. Irritant nasal and ocular symptoms
have been usual findings in industrial surveys (18, 130, 135, 214).
PA, TMA, MA, HHPA, MHHPA, MTHPA, TCPA, PMDA, HA and CA are
capable of inducing IgE-mediated sensitisation followed by allergic diseases, e.g.
allergic rhinitis often associated with allergic conjunctivitis and bronchial asthma
(Table 10). The number of reports on MA, MHHPA, PMDA, HA or CA induced
sensitisation is small. The prevalence of occupational asthma due to other cyclic
anhydrides has varied between 2-39% in industrial surveys (203).
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The allergic skin diseases caused by acid anhydrides include rare cases of IgE-
mediated contact urticaria due to HHPA, MHHPA, MTHPA, MA and CA (83, 94,
95, 102, 174), and even more rare cases of allergic contact dermatitis of type IV
allergy (57, 96).
Sensitisation and work related symptoms have been induced already at low
levels of exposure, at 10-40 µg/m3 for TMA, at 10-50 µg/m3 for HHPA and
MHHPA (mixed exposure in industrial surveys), and at 5-20 µg/m3 for MTHPA.
For PA and TCPA the corresponding exposure levels have been higher, 1 500-
17 400 µg/m3 and 140-590 µg/m3, respectively (Table 12). The prevalence of
sensitisation has increased with increasing exposure (Table 10).
When workers were exposed to a PA dust concentration of less than 100 µg/m3,
no asthmatics were found, but half of the workers had conjunctivitis and/or
rhinitis (136). In a historical cohort study the exposure to PA or MA was found
to be an uncommon cause of sensitisation at the low exposure levels measured,
8.9-11.9 µg/m3 and 1.8-2.8 µg/m3, respectively (13).
After reduction of TCPA exposure to less than 110 µg/m3 no new cases of
work-related asthma were reported (118). Lower concentrations, between 4.1-66.7
µg/m3 of TCPA have, however, induced asthma reactions in challenge tests of
sensitised workers with occupational asthma (184).
After the elimination or reduction of exposure, asthma has persisted although
it has improved in some of the follow-up studies. Occupational rhinitis often
precedes asthma, and therefore the early detection of rhinitis is important for the
prevention of more severe bronchial asthma.
The severe pulmonary disease-anaemia syndrome due to TMA and PMDA with
assumed high levels of exposure has been rare (29, 144, 212).
There are no reports on THPA induced work-related diseases.
SA injected subcutaneously has induced subcutaneous sarcomas in rats. IARC
has stated that there is limited evidence for the animal carcinogenicity of SA and
that it is not classifiable as carcinogen in humans (78).
14.3 Scientific basis for an occupational exposure limit
The data for setting occupational exposure limits is based on studies with
information on dose-response effects. The number of the studies is limited, and
some of them are not very recent. All cyclic anhydrides are considered irritants
of the mucous membranes and skin.
Data on the main critical effects, sensitisation (specific IgE antibodies), and
work-related symptoms (rhinoconjunctivitis and asthma) of PA, TMA, HHPA,
MHHPA, MTHPA, and TCPA are compiled in Table 12 in relation to exposure
levels. Occupational exposure limits for PA, TMA, and MA are presented in the
Appendix.
56
The critical effects are as follows:
Methyl tetrahydrophthalic anhydride (MTHPA): irritation of mucous membranes
of the eyes and airways and sensitisation-induced work-related diseases.
Sensitisation, work-related rhinoconjunctivitis, and asthma have been verified for
workers exposed to MTHPA levels of 5-20 µg/m3.
Hexahydrophthalic anhydride (HHPA) and Methyl hexahydrophthalic anhydride
(MHHPA): irritation of mucous membranes of the eyes and airways and
sensitisation-induced work-related diseases. Sensitisation in workers exposed to
HHPA levels of 10-50 µg/m3 has been found.
Trimellitic anhydride (TMA): irritation of mucous membranes of the eyes and
airways and sensitisation-induced work-related diseases. In a historical cohort
study of 116 workers with TMA exposure at the level of 10-40 µg/m3,
sensitisation was found according to specific IgE antibodies, as were work-related
respiratory symptoms.
Tetrachlorophthalic anhydride (TCPA): irritation of mucous membranes of the
eyes and airways and sensitisation-induced work-related respiratory diseases.
Exposure to TCPA concentrations of 140-590 µg/ m3 has caused both
sensitisation and work-related asthma. No new cases of work-related asthma have
been reported after decreasing the exposure to less than 110 µg/m3 (118). In
challenge tests of a worker with TCPA asthma, a significant asthmatic response
has been induced with concentrations between 4.1-66.7 µg/m3 of TCPA.
Phthalic anhydride (PA): irritation of mucous membranes of the eyes and airways
and sensitisation-induced work related diseases. Both work-related rhinoconjunc-
tivitis and sensitisation, but no asthma, have been found in workers exposed to
less than 100 µg/m3 of PA.
Maleic anhydride (MA): irritation of mucous membranes of the eyes and airways
and sensitisation-induced work-related diseases. Nasal metaplasia has been found
in animal studies (1 100-9 800 µg/m3 of MA). There is not enough data available
for dose-response assessment in humans.
Tetrahydrophthalic anhydride (THPA): data insufficient for assessing the critical
effect on humans.
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Table 12. Critical effects (sensitisation and work-related symptoms) in man with
corresponding exposure levels of cyclic acid anhydrides.
Acid anhydride Exposure level
(µg/m3 )
Critical effect Reference
PA 1 500 –17 400 Sensitisation
Asthma
(136)
TCPA 140-590 Sensitisation
Work-related respiratory symptoms
(118)
TMA 10-40 Sensitisation
Work-related respiratory symptoms
(13)
HHPA and MHHPA 10-50 Sensitisation (195)
MTHPA 5-20 Sensitisation
Rhinoconjunctivitis
Asthma
(134, 202)
15. Research needs
Dose-response studies of several sensitising cyclic anhydrides are few or even
lacking. Such studies are needed for assessing occupational exposure limits,
especially since the sensitising properties of the cyclic anhydrides are not similar.
Furthermore follow-up studies are needed to determine the prognosis of asthma
due to cyclic anhydrides.
Smoking and atopy as risk factors for sensitisation are not fully understood and
need to be further investigated.
Assessing exposure when products manufactured from cyclic anhydrides are
used in work processes is difficult. More knowledge is needed on the tasks
expected to involve anhydrides as thermal degradation products.
Long-term inhalation studies on animals are needed to evaluate the carcino-
genicity of acid anhydrides.
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16. Summary
Keskinen H. The Nordic Expert Group for Criteria Documentation of Health Risk
from Chemicals and the Dutch Expert Committee on Occupational Standards.
136. Cyclic acid anhydrides. Arbete och Hälsa 2004;15:1-74.
Cyclic acid anhydrides are widely used in the manufacture of resins and a variety
of chemicals. Since the introduction of phthalic anhydride (PA) several new
derivatives of cyclic acid anhydrides have came into use. Exposure to anhydrides
occurs either in powder form or as fumes when anhydrides are used at elevated
temperatures or when they are released as thermal degradation products. The
technical product of a cyclic acid anhydride may contain other related anhydrides
as impurities.
The critical effects of cyclic acid anhydrides are sensitisation, rhinoconjunc-
tivitis and asthma. Occupational rhinoconjunctivitis and asthma due to cyclic acid
anhydrides are usually IgE-mediated. Irritant work-related rhinoconjunctivitis is
often found without sensitisation to anhydrides.
Allergic contact dermatitis due to anhydrides is rare.
The sensitising potency of cyclic acid anhydrides varies. According to limited
data, trimellitic (TMA), hexahydrophthalic (HHPA), and methyl tetrahydro-
phthalic anhydride (MTHPA) are more sensitising than PA and tetrachloro-
phthalic anhydride (TCPA). Based on immunological cross-reactivity, the
sensitising potency of methyl hexahydrophthalic anhydride (MHHPA) might be
near that of HHPA and MTHPA. The level of exposure needed to cause specific
IgE antibody production and work-related symptoms in mucous membranes and
respiratory organs may be less than 10 µg/m3 for the more highly sensitising
anhydrides.
Keywords: allergic contact dermatitis, allergy, asthma, conjunctivitis, contact
urticaria, cyclic acid anhydrides, hexahydrophthalic anhydride, irritation, maleic
anhydride, methyl hexahydrophthalic anhydride, methyl tetrahydrophthalic
anhydride, occupational disease, occupational exposure limit, phthalic anhydride,
pulmonary disease-anaemia syndrome, rhinitis, tetrachlorophthalic anhydride,
tetrahydrophthalic anhydride, trimellitic anhydride.
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17. Summary in Swedish
Keskinen H. The Nordic Expert Group for Criteria Documentation of Health Risk
from Chemicals and the Dutch Expert Committee on Occupational Standards.
136. Cyclic acid anhydrides. Arbete och Hälsa 2004;15:1-74.
Cykliska syraanhydrider har en utbredd användning vid tillverkning av hartser och
en mängd andra kemikalier. Sedan ftalsyraanhydrid (PA) började användas har
flera nya derivat av syraanhydrider kommit i bruk. Exponering för anhydrider sker
antingen i form av pulver eller som rök när anhydriderna upphettas eller frigörs
som termiska nedbrytningsprodukter. Den tekniska produkten av en cyklisk
syraanhydrid kan innehålla liknande syraanhydrider som förorening.
De kritiska effekterna för cykliska syraanhydrider är sensibilisering, rinokon-
junktivit och astma. Yrkesrelaterad rinokonjunktivit och astma till följd av
syranhydrider är i regel IgE-medierade. Irritativ arbetsrelaterad rinokonjunktivit
förekommer ofta utan föregående sensibilisering för syraanhydrider.
Allergiskt kontakteksem av syraanhydrider är sällsynt.
Sensibiliseringspotentialen hos de cykliska syraanhydriderna varierar. Enligt
begränsade data är trimellitsyra- (TMA), hexahydroftalsyra- (HHPA) och
metyltetrahydroftalsyraanhydrid (MTHPA) mer sensibiliserande än PA och
tetraklorftalsyraanhydrid (TCPA). Baserat på immunologisk korsreaktivitet har
metylhexahydroftalsyraanhydrid (MHHPA) likartad sensibiliseringspotential som
HHPA och MTHPA. De exponeringsnivåer som erfordras för att ge specifikt IgE
svar och arbetsrelaterade symtom på slemhinnor och andningsorgan kan vara
lägre än 10 µg/m3 för de mer kraftigt sensibiliserande syraanhydriderna.
Nyckelord: allergi, allergisk kontaktdermatit, astma, cykliska syraanhydrider,
ftalsyraanhydrid, hygieniskt gränsvärde, hexahydroftalsyraanhydrid, irritation,
konjunktivit, kontakturtikaria, maleinsyraanhydrid, metylhexahydroftalsyra-
anhydrid, metyltetrahydroftalsyraanhydrid, rinit, tetrahydroftalsyraanhydrid,
tetrakloroftalsyraanhydrid, trimellitsyraanhydrid, trimellitsyraanhydrid-alveolit,
yrkessjukdom.
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Appendix
Occupational exposure limits for cyclic acid anhydrides in air.
Phthalic anhydride (TWA)
Country    ppm    µg/m3 Comments Year Reference
Denmark   1 000 2002 (1)
Finland      200 2002 (2)
Germany   1 000 MAK SEN 2003 (3)
Iceland 1   6 000 SEN 1999 (4)
The Netherlands   1 000
  2 000 CL
2002 (5)
Norway   2 000 SEN 2003 (6)
Sweden   2 000
  3 000 CL
SEN 2000 (7)
United States
ACGIH
NIOSH
OSHA
1
1
2
  6 100
  6 000
12 000
SEN
2003 (8)
Great Britain   4 000
12 000
MEL
STEL
SEN 2002 (9)
Abbreviations: CL, ceiling; MAK, maximum workplace concentration; MEL, maximum exposure
limit; SEN, sensitiser; STEL, short term exposure limit; TWA, time weighted average.
Trimellitic anhydride (TWA)
Country    ppm    µg/m3 Comments Year Reference
Denmark     40 2002 (1)
Finland 0.005     40 2002 (2)
Germany     40 MAK SEN 2003 (3)
Iceland 0.005     40 STEL 1999 (4)
The Netherlands     40 CL 2002 (5)
Norway 0.005     40 SEN 2003 (6)
Sweden     40
    80 CL
SEN 2000 (7)
United States
ACGIH
NIOSH
OSHA
0.005
0.005
0.005
    40
    40
CL
2003 (8)
Great Britain     40
  120
MEL
STEL
SEN 2002 (9)
Abbreviations: CL, ceiling; MAK, maximum workplace concentration; MEL, maximum exposure
limit; SEN, sensitiser; STEL, short term exposure limit; TWA, time weighted average.
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Maleic anhydride (TWA).
Country ppm µg/m3 Comments Year Reference
Denmark 0.1    400 2002 (1)
Finland    410
   810 STEL
2002 (2)
Germany    410 MAK SEN 2003 (3)
Iceland 0.1    400 SEN 1999 (4)
The Netherlands    400 2002 (5)
Norway 0.2    800 SEN 2003 (6)
Sweden 0.3 1 200 SEN 2000 (7)
United States
ACGIH
NIOSH
OSHA
0.1
0.25
0.25
   400
1 000
SEN 2003
(8)
Great Britain 1 000
3 000
MEL
STEL
SEN 2002 (9)
Abbreviations: CL, ceiling; MAK, maximum workplace concentration; MEL, maximum exposure
limit; SEN, sensitiser; STEL, short term exposure limit; TWA, time weighted average.
In addition to the occupational exposure limits for phthalic anhydride, trimellitic
anhydride and maleic anhydride presented in tables, the corresponding limits for
two other cyclic acid anhydrides have been given in Finland in 2000: Methyltetra-
hydrophthalic anhydride 170 µg/m3 and Tetrachlorophthalic anhydride 200 µg/m3,
ceiling 400 µg/m3 (4).
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